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Research Portfolio Abstract 
Background/Aims:  
People with a diagnosis of psychosis often experience stigmatising social 
encounters. These social encounters may influence the beliefs people hold, 
as research suggests that people develop a range of processes in an attempt 
to interpret information about both themselves and others. The internalisation 
of negative stereotypes about psychosis is one process used to explain how 
people's beliefs are influenced. Cognitive models highlight the relationship 
between self and social knowledge and mood. How people process social 
information might therefore have an important role in pathways to distress in 
psychosis. 
 
There is limited understanding of how different expressions of emotional 
distress might relate to the processing of social information. This research 
portfolio therefore has two aims. Firstly it aims to systematically review 
literature on the relationship between internalised stigma and distress for 
people with a schizophrenia spectrum diagnosis. It also aims to explore the 
relationship between attachment style, reflective functioning, personal beliefs 
about illness, and emotional distress in people who experience psychosis.  
 
Method:  
These two aims are addressed through two studies. The first study is 
reported in Chapter 1, where literature exploring the relationship between 
internalised stigma and measures of emotional distress was systematically 
reviewed. For this review, a search of electronic databases was conducted, 
included studies were assessed for quality, and results were outlined through 
a narrative synthesis. The empirical project reported in Chapter 2 employed a 
cross-sectional design to gather quantitative data from people who had a 
diagnosis related to psychosis. Mediation modelling was then used to explore 
cognitive appraisals as mediatory variables between attachment anxiety and 
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emotional distress whilst controlling for psychotic symptomatology as a 
potential confounding variable. 
 
Results:  
Thirty studies were included in the systematic review, with over half of these 
being cross-sectional in design. Systematic review findings indicate a 
significant association between internalised stigma and depression, however 
the association with other measures of distress was inconsistent. Limited 
data was therefore available regarding the utility of cognitive interventions 
focusing upon internalised stigma for improving symptoms of distress in 
psychosis. Results from the empirical study indicate associations between 
attachment anxiety, cognitive appraisals, and emotional distress but not 
reflective functioning. Personal beliefs about illness regarding shame and 




When reviewed systematically the relationship between internalised stigma 
and distress remained unclear. This is due in part to methodological 
limitations of included studies which did not allow the exploration of whether 
these negative beliefs about the self in relation to others around them leads 
to distress. However, findings from the empirical study suggested personal 
beliefs about illness could influence the relationship between attachment and 
emotional distress. Future interventions focusing upon internalised stigma as 
a vehicle for improving symptoms of distress in psychosis might therefore 
target perceptions of shame and control whilst recognising a wider range of 







Different sources of distress have been identified for people living with 
psychosis. Whilst some people with psychosis find their symptoms 
distressing, others find having a diagnosis of psychosis distressing in itself. 
Research suggests that if people with psychosis experience stigma in social 
situations, this might change the way they think and feel about themselves. 
How people gather information about the world around them and use this to 
guide their attention, interpretations, and predictions about themselves and 
other people can differ. These individual differences in the way people make 
sense of social situations may change the level of distress a person with 
psychosis experiences. However there is a lack of research exploring how all 
these factors are related to each other. 
A search of published research is presented in Chapter 1, where evidence is 
reviewed for a relationship between internalised stigma and distress for 
people with a schizophrenia spectrum diagnosis. Chapter 2 contains an 
exploration of the relationship between attachment style, the thoughts and 
feelings people use to make sense of themselves and others in social 
situations, and emotional distress in people who experience psychosis. 
Results show that there was a relationship between internalised stigma and 
depression, but evidence for a relationship with other forms of distress was 
inconsistent. These inconsistencies made it difficult to ascertain whether one 
factor influenced another, or the relationship was bi-directional. Interventions 
designed to reduce levels of internalised stigma by focusing on thoughts did 
not appear to be effective in reducing distress for people with psychosis. 
However findings also showed that some types of thought exerted a greater 
influence upon the relationship between attachment and distress than others. 
It is therefore recommended that future interventions seeking to reduce 
distress in people with psychosis focus on negative thoughts about the self in 




Chapter 1: Systematic Review¹ 
1.1 Title Page² 
 
 
The relationship between internalised stigma and distress experienced 
by people with a schizophrenia-spectrum diagnosis:  
A systematic review 
 
Hannah Pottera,b, Dr Wendy Prenticeb, Dr Helen Griffithsa 
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¹Produced according to author information and submission guidelines for Clinical Psychology 
Review (see Appendix A). Tables and figures however, are inserted alongside corresponding 
text as per recommendations for thesis submission. 
²Numbering of titles is included throughout for continuity of thesis portfolio, but would not be 




Individuals with a schizophrenia-spectrum diagnosis are likely to experience 
high levels of internalised stigma. Cognitive models highlight the relationship 
between self and social knowledge, and mood. The nature of association 
between internalised stigma, as one aspect of an individual's appraisal of self 
and social knowledge, and distress therefore warrants further investigation. A 
systematic review was conducted to investigate the relationship between 
internalised stigma and distress for people with a schizophrenia spectrum 
diagnosis. The search identified 30 studies published between 2002 and 
2019. Study findings indicate a significant association between internalised 
stigma and depression. However, associations between internalised stigma 
and other measures of distress such as anxiety and shame were found to be 
inconsistent. Limited data were available about the utility of interventions 
which focused upon internalised stigma for improving symptoms of distress. 
Overall, there was insufficient evidence to indicate the relationship 
directionality between internalised stigma and distress. One explanation for 
this finding is the influence of variables such as insight. Future research 
should allow for the greater expression of distress, with emphasis on 
potential directionality of this association between self and social knowledge, 
whilst controlling for potential confounding variables.  
 
 




 Internalised stigma was related to depression. 
 Internalised stigma did not consistently predict other measures of 
emotional distress. 





Significant levels of stigma around psychosis continue to exist in society, with 
Henderson et al. (2012) finding 87% of respondents reporting experiences 
such as being avoided or treated unfairly by someone who knew about their 
diagnosis. Research investigating the impact of these social experiences has 
indicated that stigmatizing social encounters may influence both the 
behaviour a person exhibits and the beliefs they hold (Mestdagh & Hansen, 
2014).  
 
Corrigan and Watson (2002) differentiated between the concepts of public 
stigma and self-stigma by comparing and contrasting their mutual 
components of stereotype, prejudice, and discrimination. Corrigan et al. 
(2010) furthered this work and explained that the term 'internalised stigma' 
can be used to describe the process of an individual becoming aware of a 
negative stereotype, agreeing with it, and then applying it to themselves. An 
individual experiencing internalising stigma might therefore develop a 
negative belief about themselves possessing a particular character weakness 
(stereotype), experience a negative emotional reaction such as lowered self-
esteem through agreement with the belief (prejudice), and then fail to pursue 
employment as a behavioural response to this prejudice (discrimination). As 
the terms self-stigma and internalised stigma are often used interchangeably 
within literature, this review will continue with the term internalised stigma (IS) 
for the purposes of clarity.  
 
Research has sought to better understand the impact of IS for people who 
live with a schizophrenia spectrum diagnosis. Systematic reviews and meta-
analyses which include studies representing participants with a schizophrenia 
spectrum diagnosis have consistently identified a robust relationship between 
IS and a range of psychosocial variables such as self-esteem and quality of 
life (Livingston & Boyd, 2010), hope and empowerment (Gerlinger et al., 
2013), withdrawal and social isolation (Oliveria, Estives, & Carvalho, 2015). 
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As such, recent researchers have increasingly focused their attention upon 
the development of interventions to reduce IS.  
 
A number of different outcomes have been evaluated within research 
examining the efficacy of IS interventions. This range of outcomes may 
reflect the different theoretical models which researchers have implemented 
in attempts to develop increasingly targeted interventions. Earlier studies 
such as Knight et al. (2006) reported upon the impact of their CBT 
intervention for IS upon positive and negative symptoms of schizophrenia. 
Whilst other earlier intervention studies focused for example upon IS with self 
efficacy as secondary outcome measures (Fung, Tsang, & Cheung, 2011), 
this appears to be largely driven by a desire to improve treatment adherence. 
Later interventions have moved towards measuring self esteem and quality 
of life (e.g. Hansson & Yanos, 2016; Yanos et al., 2019).  
 
Research has indicated that existing interventions show no significant impact 
on IS as a primary outcome measure (e.g. Link, Struening, Neese-Todd, 
Asmussen, & Phelan, 2002; Morrison et al., 2016; Russinova et al., 2014). 
However, studies report a significant positive impact on secondary outcomes 
such as hopelessness (Yanos, Roe, & Lysaker, 2011) and self-esteem 
(Morrison et al., 2016). Furthermore, through the reviewing of IS interventions 
and their change mechanisms, Yanos, Lucksted, Drapalski, Roe, and 
Lysaker (2015) suggested that cognitive challenging was one of the most 
important elements of an intervention. This is supported by evidence which 
suggests that the activation of automatic shame thoughts can be a risk factor 
for IS through discrimination being perceived as legitimate (Rusch, Todd, 
Bodenhausen, Olschewski, & Corrigan, 2010).  Despite the small effect sizes 
observed thus far, progress in developing an effective intervention has been 
considered positive when viewed in light of sample sizes employed, and the 





During the development of these increasingly targeted interventions, 
researchers have drawn upon a number of different models to better 
understand the psychological processes involved in IS. Link and Phelan's 
(2001) model drew upon social cognitive conceptualisations of stigma which 
emphasises the emotional distress and subsequent behavioural adaptations 
for a person who develops appraisals that they will be rejected due to 
experiencing social disapproval for what they perceive be their undesirable 
characteristic. Drawing increasingly upon models which emphasise emotional 
distress may have laid ground work for a later shift towards intervention 
studies investigating affect-based changes as secondary outcomes alongside 
changes in psychotic symptomatology.  
 
Link and Phelan's (2001) model identifies how labelling, for example in being 
given a mental health diagnosis, can lead to people being separated socially 
in the minds of others. Negative stereotypes about people with mental health 
difficulties are suggested to create a sense of perceived difference which 
then results in status loss and subsequent experiences of discrimination (Link 
& Phelan, 2001). However, Link and Phelan's (2001) model lacks specificity 
to schizophrenia-spectrum diagnoses as it was developed for broader 
application to the experiences of those with severe mental illness.  
 
People may be impacted differently by IS following diagnosis due to the 
differences in media portrayals and illness course of psychiatric diagnoses 
(Ross, Morgan, Jorm, & Reavley, 2019). Literature suggests that some 
interventions are better suited for people who have experienced their first 
psychotic episode whilst other interventions might be more relevant for whom 
the course of illness is more chronic (Yanos, Lucksted, Drapalski, Roe, & 
Lysaker, 2015). Systematic review (Yanos, Lucksted, Drapalski, Roe, & 
Lysaker, 2015) of these different interventions identified that a range of 
mechanisms of action had been targeted (e.g. psycho-education, cognitive 
restructuring, social skills training, narrative enhancement) thus supporting 




Birchwood et al. (2007) address this need by developing a model which was 
specific to the experience of those diagnosed with psychosis. This model 
suggested that a person might respond with distress following the 
development of beliefs of holding a shameful attribute and appraisals that 
others will reject them (Birchwood et al., 2007). Rather than drawing upon the 
stigma theory proposed by Corrigan and Watson (2002), Birchwood et al. 
(2007) based their model on Clark and Wells' (1995) cognitive behavioural 
model of social anxiety. This allowed Birchwood et al. (2007) to extend Link 
and Phelan's (2001) theory specifically for people with psychosis by providing 
a clearer mechanism by which distress might develop and be maintained. 
Birchwood et al.'s (2007) model therefore suggested that IS may lead an 
individual to fear negative evaluation or rejection by others. These fears are 
then hypothesised to result in an individual becoming hyper-vigilant to their 
performance in social situations with shame-based beliefs about the self 
increasing anxiety levels (Birchwood et al., 2007).  
 
Birchwood et al.'s (2007) model proposes a level of hyper-vigilance and fear 
of negative evaluation which would suggest that people with higher levels of 
insight would be related to higher levels of IS thus leading to poorer 
outcomes. This association between insight, IS and distress is supported by 
research (Cavelti, Rusch, & Vauth, 2014). An increasing evidence base for 
the theorised association between IS and distress may have provided 
support for researchers seeking to investigate potential secondary outcomes 
for their interventions. 
 
However Birchwood et al.'s (2007) model appears to provide a clearer 
explanation for the development and maintenance of social anxiety in 
psychosis, rather than IS and the many other emotional reactions related to 
IS as described in literature. Furthermore, Birchwood et al.'s (2007) does not 
account for the different experiences which may be encountered by people in 
different stages of illness. Stage of illness appears to be key in developing an 
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effective intervention for IS (Yanos, Lucksted, Drapalski, Roe, & Lysaker, 
2015) and differential exposure to stigma triggers may therefore be important 
within the development of  cognitions.  
  
Wood, Byrne, and Morrison (2017) therefore proposed a model which 
integrates elements of existing models of stigma, social theory, and 
Morrison's (2001) cognitive model of psychosis. The model (see Figure 1) 
extends the key aspects of cognitive, behavioural, and emotional processes 
identified within Morrison's (2001) model, and suggests how relationships 
between those components might contribute to the development and 
maintenance of IS (Wood, Byrne, & Morrison, 2017).  
 
Figure 1. Model of internalised stigma in psychosis (from Wood et al., 2017) 
 
The development of Wood et al.'s (2017) model appears to acknowledge that 
to design increasingly targeted interventions for IS, a more nuanced model 
was required to facilitate greater understanding of the appraisal-affect 
mechanism. Recognising the impact of stigma triggers and intrusions allows 
for a greater understanding of differences between IS cognitions and 
emotional distress for people with the same schizophrenia spectrum 
diagnosis at different stages of illness. Wood, Byrne, and Morrison (2017) 
argue that when applying Corrigan and Watson's (2002) theory of IS, 
stigmatising appraisals can lead to a range of complex emotional reactions 
such as social anxiety, shame/depression, and anger as three key emotional 
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responses. Whilst each of these three emotional responses has been 
described through qualitative interview with people who experience 
psychosis (Wood et al., 2015), quantitative evidence for this key component 
is also growing (e.g. Birchwood et al., 2007; Collett, Pugh, Waite, & Freeman, 
2016; Lien et al., 2018; Link, Struening, Neese-Todd, Asmussen, & Phelan, 
2002; Lysaker, Yanos, Outcalt, & Roe, 2010). 
 
Livingston and Boyd’s (2010) review highlights the need for a greater 
understanding of the relationship between IS and other psychosocial 
variables. Similarly, Wood, Byrne, Varese, and Morrison (2016) recommend 
an increased emphasis on outcomes of psychological distress when 
evaluating interventions for IS. The importance of attending to the 
relationship between IS and distress becomes clear when viewed as a key 
component of an integrative cognitive model of IS in psychosis which has yet 
to be fully explored. This paper will therefore review studies investigating the 
relationship between IS appraisals of the self in relation to others and 
distress experienced by people with a schizophrenia spectrum diagnosis. 
Through this review, it is hoped that evidence will be evaluated for a key 




1.4.1 Definition of terms 
The broader concept of self and social knowledge found within cognitive 
models was narrowed to focus upon internalised stigma for the purposes of 
this review. Within the present review, internalised stigma is defined as the 
cognitions which result from an individual applying negative stereotypes 
about their schizophrenia spectrum diagnosis to themselves (Corrigan et al., 
2010). Internalised stigma has therefore been operationalised in terms of 
how much an individual agrees or disagrees with statements which 
commonly include cognitions relating to stereotype endorsement, perceived 
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discrimination, alienation, social withdrawal, and stigma resistance (Ritsher, 
Otilingham, & Grajales, 2003).  
 
Distress was defined as affective symptoms which co-exist alongside the 
positive and negative symptoms experienced by an individual diagnosed with 
a schizophrenia spectrum disorder. This is in line with Birchwood's (2003) 
proposed pathways to emotional dysfunction since the potential for distress is 
recognised as both intrinsic to, and a reaction to the diagnosis of, psychosis. 
For the purpose of this review, associations are explored in relation to 
emotional distress and cognitive appraisals of diagnosis with a schizophrenia 
spectrum disorder. Research has highlighted depression, anxiety, anger, 
social anxiety, and shame as particularly prevalent in people who experience 
psychosis (Birchwood et al., 2007; Oliveria, Estives, & Carvalho, 2015; 
Rusch, Todd, Bodenhausen, Olschewski, & Corrigan, 2010). Measures for 
these expressions of distress have therefore been considered in this review.  
 
1.4.2 Search procedure 
A search was conducted through the electronic databases of PsychINFO, 
Embase, MEDLINE, ASSIA, and CINAHL. The Cochrane Central Register of 
Controlled Trials (CENTRAL) was also examined to identify any further 
studies soon to be published. Searches used the following keywords: 
(schizophreni* OR psychosis OR psychotic OR paranoid OR hallucination 
OR delusion) AND (stigma OR belief OR appraisal OR attitude OR schema) 
AND (distress OR depression OR anxiety OR anger OR shame OR guilt). 
After removing duplicates, the titles and abstracts of articles were screened, 
with full texts sourced for relevant studies. For cases where inclusion of an 
article was uncertain, the methods and results sections were also reviewed. 







1.4.3 Inclusion and exclusion criteria 
Studies were included if they were in English language, with a sample of 
adults aged 16-65 years, where participants meet the criteria for a primary 
schizophrenia spectrum diagnosis (schizophrenia, schizophreniform disorder, 
schizoaffective disorder, delusional disorder, psychotic disorder not otherwise 
specified) or first episode psychosis. Other criteria for inclusion were studies 
which were peer-reviewed, used a quantitative methodology, and examined 
validated measures of internalised stigma and distress. Exclusion criteria 
required that studies had included no more than 50% of participants with 
other psychiatric diagnoses or subclinical (e.g. high risk or prodromal) stages. 
Grey literature (e.g. dissertations, conference abstracts) was also excluded.  
Studies were reviewed up to and including July in 2019.  
 
1.5 Results 
After applying the above criteria, the total number of articles included in this 
review was 30 (see Figure 2). Given the quantitative nature of this review and 
the inclusion of intervention studies, the possibility of a meta-analysis was 
considered. Despite this initial possibility, evaluation of the included study 
characteristics led to concerns over the risk of bias and potential for a meta-
analysis to produce misleading results. These concerns were based upon 
findings of significant clinical diversity in the sample group, interventions 












































Figure 2. PRISMA flow diagram of search strategy 
Electronic database searches 
(PsychInfo, CENTRAL, Embase, 
ASSIA, CINAHL, and Medline) 
n = 2833 
 
 
Number included from electronic 
database search at title: 
n = 231 
 
 
Records excluded at text 
(including duplicates) from 
databases: n = 2602 
 
 
Number included from electronic 
database search at abstract: 
n = 65 
 
 
Number excluded at abstract:    
(n = 166) 
 Not schizophrenia spectrum 
population (n=12) 
 Not empirical research 
(n=24) 
 Qualitative design (n=14) 
 Not related to focus topic of 
internalised stigma (n=45) 
 No outcome measure of 
psychological distress (n=71) 
Articles included at full text: 
n = 28 
Full text references excluded: 
(n = 37) 
 
 Not English language (n=4) 
 Qualitative study design 
(n=11) 
 Measures not related to 
focus topic (n=22) 
Final list of included articles: 
n = 30  
(8 intervention, 22 observational) 
Additional articles added from 
article reference: n = 2 
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1.5.1 Overview of the study characteristics 
Studies took place in a range of locations including Europe, North America, 
and Asia. Over half the studies (n = 16) used a cross sectional design. While 
eight intervention studies were identified, only six of these were RCTs. 
Sample size ranged from n = 21 to n = 927.  
 
The majority of studies (n = 19) included participants exclusively with a 
schizophrenia spectrum diagnosis, or included participants with a 
schizophrenia spectrum diagnosis alongside other severe and enduring 
mental health diagnoses (n = 5). However a small number (n = 3) focused 
upon first episode psychosis only. 
21 
 
Table 1. Demographic and methodological features of included studies (presented chronologically) 
Intervention Studies 
Author, date and 
location 
 
Method Measurement  Schizophrenia 









Link et al. (2002)  
USA 
RCT 
8 week social stigma psycho-
education group vs control 
Self-report S, 36% 
NAP, 14% 
n = 88 
 
Female = 39% 
Drop out: 38% 40.9 
(NR) 
Knight et al. (2006) 
UK 
Time series 
7 week CBT group vs waiting 
list control 
Self-report SSD, 100% n = 21 
 
Female = 48% 
Drop out: 10% 39.3 
(8.8) 
Lysaker et al. 
(2010) USA 
Cohort 
Baseline and 5 month follow-
up, <20h per week vocational 
rehabilitation 
Self-report SSD, 100% n = 78 
 
Female = 15% 
Drop out: NR 46.7 
(8.7) 
Russinova et al. 
(2014) USA 
RCT 
10 week peer-led photovoice 
psycho-education group vs 
waiting list control 




n = 82 
 
Female = 68% 
Drop out: 5% 18+  
With 68% aged 
40+ 
Morrison et al. 
(2016) UK 
RCT 
12 individual sessions of CT vs 
TAU. 




n = 29 
 
Female = 21% 
Drop out: 7% 34.3 
(13.3) 




40 individual sessions of MERIT 
vs TAU 
Self-report S, 67% 
SA, 33% 
n = 70 
 
Female = 30% 
Drop out: 49% 40.0  
(11.3) 
Ho et al.  
(2018) Hong Kong 
RCT 
1 year extended early 
intervention vs TAU 2 year step 
down intervention 
Observer rated by 
interview 
FEP, 100% n = 160 
 
Female = 47% 
Drop out: 15% 23.0 
(3.3) 
Wood et el. 
(2018) UK 
RCT 
2 hour CBT session vs SPE 
intervention 
Self-report SSD, 100% n = 30 
 
Female = 23% 







Author, date and 
location 
 









Ritsher & Phelan 
(2004) USA 
Cross sectional 
Baseline and 4-month follow up 
Self-report SSD, 100% 
 
n = 82 
 
Female = 9% 
Drop out: 35% 51.0 
(10.0) 
Birchwood et al. 
(2006) UK 
Cross sectional  
Between groups comparison of 
Social anxiety vs No social 
anxiety  
Observer rated by 
interview 
FEP, 100% n = 79 
 
Female = 23% 
Drop out: NR NR 




Self-report SSD, 100% n = 172 
 
Female = 40% 
Drop out: NR 39.6 
(11.0) 




Self-report S, 100% n = 127 
 
Female = 44% 
Drop out: NR 38.9 
(10.7) 





mood scales blind 
to self-rated 
outcomes.  
FEP, 100% n = 102 
 
Female = 29% 
Drop out: NR 26.9 
(7.4) 




Self-report SSD, 100% n = 172 
 
Female = 46% 
Drop out: 14% 37.3 
(11.9) 
Ben-Zeev et al. 
(2012) USA 
Longitudinal 
6 x assessments daily over 1 
week period 
Self-report SSD, 100% n = 24 
 
Female = 29% 





Cross-sectional Comparison of 
four groups 
 
Self-report FEP 44%  
FEP/SAD 15%  
SAD 23% 
HC 18% 
n = 135 
 
Female = 47% 
Drop out: NR 25.2  
(4.9) 
 
Cavelti et al. 
(2014) Switzerland 
Longitudinal 
Baseline and 1 year follow-up 
with no intervention 
Self-report and 
observer rated 
SSD, 100% n = 133 
 
Female = 35% 
 








Self-report SSD, 100% n = 284 
 
Female = 42% 
 
Drop out: NR 39.9 
(12.6) 
Lien et al. 
(2015) Taiwan 




n = 170 
 
Female = 50% 
Drop out: 6% 43.6 
(11.8) 
Valiente et al. 
(2015) Spain 
Cross sectional 
Focus on persecutory beliefs 
Self-report SSD, 100% n = 51 
 
Female = 43% 
Drop out: 8% 31.0 
(8.4) 
Yoo et al. 
(2015) Korea 
Cross sectional Self-report SSD, 100% n = 87 
 
Female = 41% 
Drop out: NR 34.5 
(9.8) 
Boyd et al. (2016) 
USA 
Longitudinal 
Baseline, 3-month, and 6-
month follow up 
Self-report SSD, 100% n = 927 
 
Female = 6% 
Drop out: 17% 49.6 
(8.5) 
Collett et al. 
(2016) UK 
Cross sectional 
Between groups comparison of 
persecutory delusion vs non-
clinical control 
Self-report NAP, 50% 
Control, 50% 
n = 42 
 
Female = 52% 
Drop out: NR 43.8  
(12.2) 
Espinosa et al. 
(2016) Spain 
Cross sectional Self-report SSD, 100% n = 50 
 
Female = 39% 
Drop out: NR 32.5 
(9.6) 
Murri et al. 
(2016) Italy 
Cross sectional Self-report and 
observer rated 
S, 100% n = 89 
 
Female = 30% 
Drop out: NR 42.2 
(10.8) 




Between groups comparison of 
SSD vs SSD with SP 
Self-report SSD, 69% 
SSD/SP, 31% 
n = 61 
 
Female = 51% 
Drop out: 13% 35.6 
(9.6) 
Lagger et al. 
(2018) Austria 
Longitudinal 
Baseline, 3-month, and 6-
month follow up 
Self-report SSD, 100% n = 284 
 
Female = 35% 
Drop out: 65% 39.6 
(11.2) 
Lien et al. 
(2018) Taiwan 
Cross sectional Self-report SSD, 100% n = 190 
 
Female = 45% 





et al. (2019) 
Spain 
Cross sectional Self-report SSD, 100% n = 216 
 
Female = 28% 
Drop out: NR 43.9 
(9.3) 
Pellet et al. (2019) 
Switzerland 
Longitudinal 
Baseline, 2-month, and 6-
month follow up  
Observer rated by 
interview 
SSD, 100% n = 80 
 
Female = 39% 
Drop out: 11% 39.9 
(10.9) 
 B Bi-polar, CT Cognitive therapy, D Depression, FEP First episode psychosis, HC Healthy control, MD Mood disorders, MERIT Metacognitive Reflection 
and Insight Therapy, NAP Non-affective psychosis, NR Not recorded, RCT Randomised control trial, S Schizophrenia, SA Schizoaffective disorder, SP 





1.5.2 Quality assessment 
Intervention studies were assessed using the Quality assessment tool for 
quantitative studies (EPHPP; Effective Public Health Practice Project, 1998). 
Cross sectional and longitudinal studies were assessed using an amended 
version of the Quality Assessment Tool for Observational Cohort and Cross 
Sectional Studies (QAT; National Institute for Health, 2017). By using the 
QAT, it was possible to further differentiate the quality as piloting of the 
EPHPP indicated a floor effect. Quality assessments were completed by the 
author, with 30% subjected to independent secondary review by a peer. The 
initial inter-rater reliability was moderate (k = 0.65) due to differences in the 
identification of confounding variables, however any discrepancies in ratings 
were resolved during early discussion. Quality assessment ratings are 
outlined in Table 2.  
 
For the experimental studies, global ratings of bias were mixed which 
reflected the strong methodology of RCTs in comparison to intervention 
studies (Link, Struening, Neese-Todd, Asmussen, & Phelan, 2002; Knight, 
Wykes, & Hayward, 2006) which did not use blinding procedures or control 
for confounding variables. Only one study (Morrison et al., 2016) rated 
strongly in the selection bias category, as the other studies had not sampled 
from a variety of services. It is of note that studies varied in their controlling of 
confounding variables and explicit descriptions of blinding procedures for 
group allocation.  
 
There was greater variance in the global ratings of bias for the cross 
sectional and longitudinal studies than for the experimental studies. This 
variety in global ratings may be understood in the context of; two studies 
which did not clearly state their research question or objective, six studies 
which did not describe any statistical adjustment for confounding variables, 
and four of the five longitudinal studies which experienced significant losses 
to follow up. Furthermore, only three studies gave a sample size justification 
or power description. 
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Table 4.1 Effective Public Health Practice Project (EPHPP) assessment of bias for intervention studies 
Study Selection bias Study design Confounders 
 






Link et al.  
(2002)  
Moderate Strong Weak Weak Strong Moderate Weak 
Knight et al.  
(2006)  
Moderate Weak Weak Weak Strong Strong Weak 
Lysaker et al. 
(2010) 
Moderate Weak Moderate Moderate Strong Moderate Moderate 
Russinova et al. 
(2014)  
Moderate Strong Strong Moderate Strong Strong Strong 
Morrison et al. 
(2016)  
Strong Strong Strong Strong Strong Strong Strong 
de Jong et al. 
(2018)  
Moderate Strong Strong Strong Moderate Moderate Strong 
Ho et al.  
(2018)  
Moderate Strong Strong Weak Strong Moderate Moderate 
Wood et el. 
(2018)  









Table 4.2 National Institute of Health (NIH) assessment of bias for observational studies 













Phelan (2004)  
Yes Yes No No Yes Yes Yes Yes Good 
Birchwood et 
al. (2006)  
Yes Yes No NA NA Yes Yes Yes Good 
Vauth et al. 
(2007)  
Yes Yes Yes NA NA Yes Yes No Fair 
Kleim et al. 
(2008)  
Yes Yes No NA NA Yes Yes No Fair 
Norman et al. 
(2011)  
Yes Yes No NA NA No No Yes Poor 
Sibitz et al. 
(2011)  
Yes Yes No NA NA Yes Yes Yes Good 
Ben-Zeev et 
al. (2012)  




Yes Yes No NA NA Yes Yes Yes Good 
Cavelti et al. 
(2014)  
Yes Yes No Yes Yes No No Yes Fair 
Schrank et al. 
(2014)  
Yes Yes No NA NA Yes Yes No Good 
Lien et al. 
(2015)  
No Yes Yes NA NA Yes Yes No Good 
Valiente et 
al.(2015)  
Yes Yes No NA NA Yes Yes No Good 
Yoo et al. 
(2015)  
Yes Yes No NA NA No No Yes Poor 
Boyd et al. 
(2016) 
Yes Yes No No Yes Yes Yes Yes Fair 
Collett et al. 
(2016)  
Yes Yes Yes NA NA Yes Yes Yes Good 
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Espinosa et al. 
(2016)  
Yes Yes No NA NA Yes Yes No Fair 
Murri et al. 
(2016) 
Yes Yes No NA NA No No Yes Fair 
Vrbova et al. 
(2017)  
Yes Yes No NA NA No Yes Yes Fair 
Lagger et al. 
(2018)  
Yes Yes No No Yes Yes Yes Yes Good 
Lien et al. 
(2018)  
Yes Yes No NA NA Yes Yes Yes Good 
Morgades-
Bamba et al. 
(2019) 
Yes Yes No NA NA Yes Yes Yes Good 
Pellet et al. 
(2019) 
Yes Yes No Yes Yes No No Yes Fair 










1.5.3 Overview of the interventions for internalised stigma  
The interventions described within included studies varied, with the four 
RCTs from 2016 onwards (Ho et al., 2018; de Jong et al., 2018; Morrison et 
al., 2016; Wood, Byrne, Enache, & Morrison, 2018) offering an individual 
intervention format rather than the group format preferred in earlier studies 
(Knight, Wykes, & Hayward, 2006; Link, Struening, Neese-Todd, Asmussen, 
& Phelan, 2002; Lysaker, Yanos, Outcalt, & Roe, 2010; Russinova et al., 
2014). Interventions for internalised stigma, with secondary distress 
outcomes reported, varied.  
 
Of the experimental studies reviewed, 50% drew upon cognitive models for 
their intervention (de Jong et al., 2018; Knight, Wykes, & Hayward, 2006; 
Morrison et al., 2016; Wood, Byrne, Enache, & Morrison, 2018). These 
cognitive based interventions ranged from a brief formulation session (Wood, 
Byrne, Enache, & Morrison, 2018), to a more intensive 12-sessions utilising 
strategies to target appraisals and negative beliefs about self (Morrison et al., 
2016). Three other studies (Ho et al., 2018; Link, Struening, Neese-Todd, 
Asmussen, & Phelan, 2002; Russinova et al., 2014) delivered some form of 
psycho-education with a focus on providing information and opportunities to 
discuss the meaning and impact of stigmatising stereotypes alongside 
strategies to cope proactively. One study (Lysaker, Yanos, Outcalt, & Roe, 
2010) followed a cohort of participants who were provided work placements 
of up to 20 hours per week over the course of five months.   
 
1.5.4 Overview of the outcome measures used 
Table 1 shows that studies commonly employed self report measures to 
investigate both internalised stigma and distress (n = 23). However, there is 
little agreement regarding the outcome measures used to reliably assess 
either internalised stigma or distress in the target population. Measures have 
therefore been outlined in Table 3 alongside key study findings. 
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Table 3.1.1 Relationship between internalised stigma and depressive symptoms - intervention studies 
Cohort 
 
IS measure Depression 
measure 
Association Clinical relevance 
Link et al.  
(2002)  
PDD CES-D r = 0.41, p <0.001 
 
B = 0.606, n.s., d = 1.53 
 
IS associated with depression and explained 41.4% of the 
variance within a multiple regression.  
Impact of stigma intervention upon depression at follow-up not 
in the expected direction.  
Knight et al.  
(2006)  
PDD BDI-II Estimated change -6.46  
p = .008, d = 0.70 
 
 
Clinically significant reduction in depressive symptoms across 
the IS treatment period.  
Trend in symptom reduction continued at follow-up but change 
estimate not significant. 
Russinova et al. 
(2014)  
ISMI CES-D α = 0.92, p = .90, d = 0.03 No difference in depressive symptoms between IS intervention 
and control group post-, or follow-up.  
Morrison et al. 
(2016)  
ISMI, SIMS BDI-PC 
 
F = 4.39, p = 0.048, d = 0.59 Significant effect in favour of IS intervention for reducing 
depressive symptoms compared to control group.  
However this effect did not remain at follow-up. 
de Jong et al. 
(2018) 
ISMI QIDS-SR B = -0.07, n.s., d = -0.08 No significant effects of intervention in reducing depressive 
symptoms compared to control group. 
Ho et al. 
(2018) 
SSS-S CDSS B = 0.04, p = 0.021, d = 0.40 IS associated with depressive symptoms  
Wood et al. 
(2018) 
ISMI BDI-PC F = 0.682, p = 0.416, d = -0.27 
 
F = 1.411, p = 0.246, d = -0.33 
No difference in depressive symptoms between IS intervention 
and control group post- therapy. 
No difference in depressive symptoms between groups at 
follow-up.  
α Alpha, β Standardised Beta, B Un-standardised Beta, BDI - Beck Depression Inventory (Beck et al., 1961), BDI-PC - Beck Depression Inventory for 
Primary Care (Winter et al., 1999), CDSS - Calgary Depression Scale for Schizophrenia (Addington et al., 1993), CES-D - Centre of Epidemiological 
Studies Depression (Radloff, 1977), d Cohen's d effect size measure, IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et 
al., 2003), n.s. Non significant, PDD - Perceived Devaluation Discrimination Scale (Link, 1985; Link et al., 1991; Link et al., 2002), QIDS-SR - Quick 
Inventory of Depressive Symptomatology-Self Report (Rush et al., 2003), r Correlation coefficient, Rho Spearman's Rho, SIMS - Semi-structured Interview 
Measure of Stigma (Wood & Morrison, 2016), SSS-S - Self Stigma Scale Short Form (Mak & Cheung, 2010), SSMI - Self-Stigma of Mental Illness Scale 








IS measure Depression 
measure 
Association Clinical relevance 
Ritsher & Phelan 
(2004) 
ISMI, PDD CES-D β = 0.24, p <0.05 
 
β = -0.12, n.s. 
IS predictive of depressive symptoms at follow-up when 
controlling for level at baseline. 
If stigmatising experiences occur without internalising then no 
significant effect.  
Vauth et al. 
(2007) 
PDD CES-D/ADS r = 0.19, p <0.01 Significant association between perceived stigma and 
depressive symptoms.  
Kleim et al. 
(2008) 
PDD CES-D/ADS r = -.03, n.s. No significant association between perceived stigma and 
depression.  




r = 0.25, p <.05 
r = 0.53, p <.001 
Significant association between IS and depressive symptoms 
as measured by both CDSS and POMS-D.  




CES-D/ADS r = 0.28, p <0.01 
r = 0.20, p <0.01 
Significant association between depressive symptoms and IS 
as measured by both the ISMI and PDD.  
Ben-Zeev et al. 
(2012)  
SSMI BDI, PANAS r = 0.55, N/R Significance of association between IS and depression not 
recorded.  
Cavelti et al. 
(2014) 
SSMI CDSS, BDI-II β = 0.27, p = 0.05 Increased IS between baseline and follow-up predicted 
depressive symptoms at 12 months.  
Schrank et al. 
(2014) 
ISMI CES-D/ADS r = 0.50, p = 0.01 Significant association between IS and depressive symptoms.  
Lien et al. 
(2015) 
ISMI BDI-II r = 0.36, p <0.01 Significant association between IS and depressive symptoms.  
Valiente et al. 
(2015) 
ISMI BDI-II β = -0.33, p <0.05 IS moderates the association between insight and depression 
explaining 7% of the variance in depressive symptoms. 
Yoo et al. 
(2015) 
ISMI BDI r = 0.521, p = 0.001 Significant association between IS and depressive symptoms.  




β = 0.19, p <0.001  
 
β = 0.18, p <0.001 
IS was associated with increased depressive symptoms at 3-
months when controlling for depression at baseline. 
This association continued at 6- month follow-up.  
Collett et al. 
(2016) 





Espinosa et al. 
(2016) 
ISMI BDI-II r = 0.33, p <0.05 Significant association between IS and depressive symptoms.  
Murri et al. 
(2016) 
ISMI, PDD CDSS β = -0.5, N/R The association between insight and depression was partially 
mediated by IS. 
 
Lagger et al. 
(2018) 
ISMI CES-D/ADS Rho = 0.38, p = 0.02 IS and depressive symptoms were related in their change over 
time.  
Lien et al. 
(2018) 
ISMI BDI-II r = 0.55, p <0.01 Significant association between IS and depressive symptoms.  
Pellet et al. 
(2019) 
SS CDSS r = 0.41, p = 0.001 IS predictive of depressive symptoms at follow-up, however 
this relationship was not significant after controlling for 
depressive symptoms at baseline. 
β Standardised Beta, BDI - Beck Depression Inventory (Beck et al., 1961), CDSS - Calgary Depression Scale for Schizophrenia (Addington et al., 1993), 
CES-D - Centre of Epidemiological Studies Depression (Radloff, 1977), CES-D/ADS - German adapted shortened version of the CES-D (Hautzinger & 
Bailer, 1993), IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et al., 2003), N/R Not reported, n.s. Non significant, PANAS 
- Positive And Negative Affect Schedule (Watson et al., 1988), POMS - Profile Of Mood States (Curran et al., 1995), r Correlation coefficient, Rho 
Spearman's Rho, SCL-90-R - Symptom Checklist (Derogatis et al., 1973), SS - Stigma Scale (King et al., 2007), SSMI - Self-Stigma of Mental Illness Scale 
(Corrigan et al., 2007). 
 
Table 3.2.1 Relationship between internalised stigma and anxiety symptoms - intervention studies 
Cohort IS measure Anxiety 
measure 
Association Clinical relevance 
 
Lysaker et al. 
(2010) 
ISMI MAQ r = 0.37, p <.005 
 
N/R, n.s. 
Significant association between IS and anxiety symptoms.  
Social anxiety was not correlated with intervention 
participation.  
Morrison et al. 
(2016)  
ISMI, SSMI SIAS F = 3.19, p = 0.088, d = 0.68 No difference in effect of IS intervention for reducing social 
anxiety symptoms compared to control group.  
d Cohen's d effect size measure, IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et al., 2003), MAQ - Multidimensional 
Anxiety Questionnaire (Reynolds, 1999), N/R Not reported, n.s. Non significant, r Correlation coefficient, SIAS - Social Interaction Anxiety Scale (Mattick & 




Table 3.2.2 Relationship between internalised stigma and anxiety - observational studies 
 
Cohort IS measure Anxiety 
measure 
Association Clinical relevance 
 
Birchwood et al. 
(2006) 
PBIQ SIAS, FNE O.R. 1.4, p = 0.038 Shame about psychosis was a predictor of social anxiety.  




r = .28, p <.01 
r = .31, p <.01 
Significant association between IS and anxiety symptoms as 
measured by both the HARS and POMS-A.  
Ben-Zeev et al. 
(2012)  
SSMI BAI, PANAS r = .55, N/R Significance of association between IS and anxiety not 
recorded  
Michael & Birchwood 
(2013) 
PBIQ SIAS, SPS F 1,79 = 8, p <0.05 Shame about psychosis was significantly higher in the social 
anxiety group than control.  
Valiente et al. 
(2015) 
ISMI BAI β = -1.59, p = 0.12 IS did not moderate association between insight and anxiety 
symptoms.  
Espinosa et al. 
(2016) 
ISMI BAI r = 0.97, n.s. No significant association between IS and anxiety was 
observed  
Vrbova et al. 
(2017) 
ISMI BAI, LSAS t = 4.251, p = 0.0001 IS levels were greater in the social anxiety group when 
compared to controls.  
β Standardised Beta, BAI - Beck Anxiety Inventory (Beck et al., 1988), FNE - Fear of Negative Evaluation Scale (Watson & Friend, 1969), HARS - Hamilton 
Anxiety Rating Scale (Riskind et al., 1987), IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et al., 2003), LSAS - Liebowitz 
Social Anxiety Scale (Liebowitz, 1987), N/R Not reported, N.S. Non significant, O.R. Odds ratio, PANAS - Positive And Negative Affect Schedule (Watson et 
al., 1988), PBIQ - Personal Beliefs about Illness Questionnare (Birchwood et al., 1993), POMS - Profile Of Mood States (Curran et al., 1995), r Correlation 
coefficient, SIAS - Social Interaction Anxiety Scale (Mattick & Clarke, 1998), SPS - Social Phobia Scale (Mattick & Clarke, 1998), SSMI - Self-Stigma of 








Table 3.3.1 Relationship between internalised stigma and shame symptoms - intervention studies 
Cohort 
 
IS measure Shame 
measure 
Association Clinical relevance 
Link et al. 
(2002) 
PDD SRF r = 0.48 p <0.001 
 
B = -0.072, n.s., d = -0.76 
IS is associated with feeling ashamed and explained 38.9% of 
variance within a multiple regression.  
Impact of stigma intervention at follow-up was in the expected 
direction.  
Morrison et al. 
(2016)  
ISMI, SIMS ISS F = 4.84, p = 0.039, d = 0.56 Significant effect in favour of IS intervention for reducing 
shame symptoms compared to control group.  
However this effect did not remain at follow-up. 
B Un-standardised Beta, d Cohen's d effect size measure, IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et al., 2003), 
ISS - Internalised Shame Scale (Cook, 1987), N/R Not reported, n.s. Non significant, PDD - Perceived Devaluation Discrimination Scale (Link, 1985; Link et 
al., 1991; Link et al., 2002), r Correlation coefficient, SIMS - Semi-structured Interview Measure of Stigma (Wood & Morrison, 2016), SRF - Stigma Related 




Table 3.3.2 Relationship between internalised stigma and shame - observational studies 
Cohort 
 
IS measure Shame 
measure 
Association Clinical relevance 





OSS, ISS F = 9.7 p <0.001, d = 1.2 Participants in the social anxiety group appraised their 
psychosis as shameful, reporting significantly greater shame 
levels than the non-social anxiety group.  
Michail & Birchwood  
(2013) 
PBIQ OSS, ISS N/R, p = 0.41 There was no significant difference in shame symptoms 
between the psychosis and control group  
d Cohen's d effect size measure, IS Internalised Stigma, ISS - Internalised Shame Scale (Cook, 1987), N/R Not reported, OAS - Other as Shamer Scale 





Table 3.4.1 Relationship between internalised stigma and negative affect (hostile, afraid, distressed) - observational studies 
Cohort 
 
IS measure Affect 
measure 
Association Clinical relevance 
Norman et al. 
(2011) 
SSMI POMS-A/H r = 0.28, p <.01 Significant association between IS and negative affect as 
measured by the POMS-Anger/Hostility subscale.  
Ben-Zeev et al. 
(2012)  




ISMI PANAS r = .59, p <.001 
 
β = 0.20, p = 0.002 
Significant association between IS and negative affect. 
Direct effect of IS on negative affect partially mediated by self-
esteem. 
β Standardised Beta, d Cohen's d effect size measure, IS Internalised Stigma, ISMI - Internalized Stigma of Mental Illness Scale (Ritsher et al., 2003), N/R 
Not reported, PANAS - Positive And Negative Affect Schedule (Watson et al., 1988), POMS - Profile Of Mood States (Curran et al., 1995), r Correlation 
coefficient, SSMI - Self-Stigma of Mental Illness Scale (Corrigan et al., 2007). 
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For the internalised stigma measures, a shift whereby some consensus 
around the use of the Internalised Stigma of Mental Illness (ISMI) scale 
(Ritsher, Otilingham, & Grajales, 2003) appears to occur from 2010-2011 
onwards. This may reflect the work of Brohan, Slade, Clement, and 
Thornicroft (2010) who, through their systematic review of outcome 
measures, distinguished between perceived stigma and internalised stigma. 
Research now suggests that the Perceived Discrimination and Devaluation 
(PDD) scale (Link, Struening, Neese-Todd, Asmussen, & Phelan, 2002) may 
measure both these conceptually different aspects of stigma (Wood, Byrne, 
Varese, & Morrison, 2016). The questionable reliability and validity of the 
PDD as a measure of internalised stigma therefore negatively affects the 
overall conclusions which might be drawn from a dataset including this 
measure.  
 
Birchwood and his colleagues (Birchwood et al., 2007; Birchwood, Jackson, 
Brunet, Holden, & Barton, 2012; Michail & Birchwood, 2013) appear to have 
approached this concept differently, through their development of the 
Personal Beliefs about Illness Questionnaire. The PBIQ contains a set of 
subscales designed to capture key sets of negative beliefs an individual 
might hold about the cause, meaning, and consequences of psychosis 
(Birchwood, Jackson, Brunet, Holden, & Barton, 2012). As such, it might be 
considered well placed to investigate Brohan, Slade, Clement, and 
Thornicroft's (2010) conceptualisation of internalised stigma as an individual's 
internalisation of cognitions and emotions in response to public stigma. 
However the area of internalised stigma is relatively new, and therefore 
continues to develop more sophisticated measures for capturing these 
internalised stigma cognitions. 
 
Again there was little agreement regarding the outcome measure used for 
depressive symptoms, and three studies chose to use more than one 
approach to quantify this outcome. As described within Cavelti, Rüsch, and 
Vauth (2014), the choice to employ observer rated measures alongside 
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participants' self report was related to the potential confounding effects of 
participant insight into illness when completing self report measures.  
 
Other distress outcomes measured included anxiety (n = 6), social anxiety (n 
= 4), shame (n = 4), and negative affect (n = 3). One study (Lysaker, Yanos, 
Outcalt, & Roe, 2010) chose to use the Multidimensional Anxiety 
Questionnaire (MAQ) to specifically investigate social anxiety. The number of 
studies focusing on these other forms of distress are noticeably fewer than 
the twenty six targeting depression, and continues to be a developing area 
for research.  Significant differences (t = 3.175, p<0.005) were found in more 
general anxiety levels between groups comparing those with and without 
social anxiety in the one study (Vrbova, Prasko, Ociskova, & Holubova, 
2017) which contained a measure specifically for social anxiety alongside a 
more general measure of anxiety.  
 
1.6 General discussion 
The associations between internalised stigma and psychological distress as 
measured by the studies within this review are summarised in Table 3. 
Associations between IS and each of the key emotional responses 
highlighted within Wood, Byrne, and Morrison's (2017) model are considered 
in the following sections. 
Depression 
The principle outcome of distress used was depression, employed by 26 of 
the 30 included studies. Overall, findings suggest that there is a significant 
positive association between internalised stigma and level of depressive 
symptoms (Collett, Pugh, Waite, & Freeman, 2016; Espinosa, Valiente, 
Rigabert, & Song, 2016; Lien et al., 2015; Lien et al., 2018; Norman, Windell, 
Lynch, & Manchanda, 2011; Schrank, Amering, Grant Hay, Weber, & Sibitz, 
2014; Sibitz et al., 2011; Vauth, Kleim, Wirtz, & Corrigan, 2007; Yoo et al., 
2015). This overall pattern might be considered in line with predictions made 
in all three of the IS models (i.e. Link & Phelan, 2001; Birchwood et al., 2007; 
Wood et al., 2017) previously discussed.  
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However in contrast to this pattern, Kleim et al. (2008) did not find a 
significant or positive association between internalised stigma and 
depressive symptoms. Despite Kleim et al. (2008) recruiting a sample size of 
127 participants, all with a diagnosis of schizophrenia, which is appropriate to 
observe the effect without heightened risk of Type II error, it is necessary to 
consider other contributing factors. Other factors which may contribute to the 
observed contrasting pattern in association between IS and depressive 
symptoms include the possible impact of confounding variables left 
uncontrolled. The importance of recognising potential confounding variables 
is acknowledged through the QAT (National Institute for Health, 2017) and is 
a factor that limits Kleim et al.'s (2008) study in comparison to other 
observational studies.  
 
One controversial confounding variable is the potential overlap between 
depression and negative psychotic symptoms. Evidence from studies which 
do control for this potential overlap provides further support for the dominant 
pattern (Cavelti, Rusch, & Vauth, 2014; Ho et al., 2018; Murri et al., 2016). 
This might also highlight the necessity of an increasing shift in emphasis by 
Birchwood et al. (2007) and later Wood et al. (2017) towards a model specific 
to the experiences of people with psychosis. 
 
When entered into regression analyses, internalised stigma was found to be 
an independent predictor of depression (Boyd, Hayward, Bassett, & Hoff, 
2016; Cavelti, Rusch, & Vauth, 2014; Link, Struening, Neese-Todd, 
Asmussen, & Phelan, 2002; Ritsher & Phelan, 2004; Valiente, Provencio, 
Espinosa, Duque, & Everts, 2015). Furthermore, evidence from Lagger, 
Amering, Sibitz, and Schrank (2018) suggests that internalised stigma and 
depression relate in their changing levels over time. Interestingly, one study 
(Ritsher & Phelan, 2004) supported evidence for this pattern but asserted 
that if stigmatising experiences occurred without the individual internalising 




Whilst no studies report on depression as a primary outcome, experimental 
studies which reported upon depression as a secondary outcome provide 
little support for the use of stigma focused interventions in reducing 
psychological distress in the form of depressive symptoms. One early study 
(Link, Struening, Neese-Todd, Asmussen, & Phelan, 2002) reported a non 
significant intervention effect upon depression that was not in the expected 
direction for their experimental group. This outcome might be better 
understood in the context of a psycho-education based intervention being 
employed which focused on teaching participants about recognising the 
possibility of internalising stigma and choosing ways to cope with stigmatising 
encounters rather than any cognitive restructuring to support change in 
existing cognitions despite acknowledging high levels of IS in the sample 
group (Link, Struening, Neese-Todd, Asmussen, & Phelan, 2002). Study 
findings are further confounded by the use of an internalised stigma measure 
more recently found to be unreliable.  
 
Two studies (Knight, Wykes, & Hayward, 2006; Morrison et al., 2016) 
reported that their intervention designed to focus upon internalised stigma 
had resulted in a significant (moderate effect size) reduction in depression 
symptoms post-treatment, but that this effect had not been observed at follow 
up. Two further studies (de Jong et al., 2018; Wood, Byrne, Enache, & 
Morrison, 2018) reported that their internalised stigma based intervention did 
not exert any significant effect upon depressive symptoms reported by 
participants when they were compared to the control group.  
 
Findings from the reviewed studies are therefore inconclusive as to whether 
treatment interventions designed to reduce internalised stigma can produce a 
lasting reduction in participants' depressive symptoms. Whilst it is possible to 
find evidence for interventions that reduce an individual's sense of 
internalised stigma, the challenge remains for researchers and clinicians to 
develop an intervention that reduces the emotional distress people 




Nine studies utilised measures of internalised stigma and anxiety. Whilst two 
studies (Lysaker, Yanos, Outcalt, & Roe, 2010; Norman, Windell, Lynch, & 
Manchanda, 2011) reported a significant positive association between 
internalised stigma and anxiety, Espinosa, Valiente, Rigabert, and Song's 
(2016) non significant findings do not support this as a more general pattern 
of relationship. Two studies notable for their specific focus upon social 
anxiety provide tentative evidence for a relationship between the experience 
of internalised stigma and social anxiety, as opposed to more general anxiety 
symptoms (Birchwood et al., 2007; Michail & Birchwood, 2013). This appears 
consistent with the work of Link and Phelan's (2001) and Birchwood et al. 
(2007), as their models of IS both predict that emotional distress results from 
an individual developing appraisals that others will reject them.  
 
In Birchwood et al.'s (2007) study, participants with psychosis who believed 
their diagnosis to be shameful were found to be a predictor of social anxiety 
symptoms. Michail and Birchwood's (2013) later study provides further 
support for a relationship between internalised stigma and social anxiety, as 
they found that participants with psychosis expressed higher levels of shame 
about their diagnosis if they were also socially anxious. However, whilst a 
relationship appears to exist between internalised stigma and social anxiety, 
the directionality of possible effect the variables exert on each other within 
this relationship remains unclear. 
 
Shame 
Four studies utilised measures of internalised stigma and shame, however 
only one of these (Link, Struening, Neese-Todd, Asmussen, & Phelan, 2002) 
investigated the association to report a significant positive relationship 
between them. The two studies (Link, Struening, Neese-Todd, Asmussen, & 
Phelan, 2002; Morrison et al., 2016) with interventions designed with a focus 
on internalised stigma reported post treatment reductions in shame. Despite 
findings of an effect on shame levels in the expected direction, it was not 
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significant at follow up. These inconsistent effects may be in part explained 
by the other studies investigating shame.  
 
While participants with psychosis did report significant levels of shame, and 
appraised their diagnosis as shameful, this was in a group who also reported 
high levels of social anxiety (Birchwood et al., 2007). When controlling for 
social anxiety, Michail and Birchwood (2013) did not find a significant 
difference in shame levels for participants with psychosis with similar 
appraisals of their diagnosis.  These outcomes are therefore inconclusive as 
to the nature of the relationship between internalised stigma and shame. 
Wood et al.'s (2017) more nuanced model with bi-directional predictions 
between key aspects of IS might therefore be able to provide greater clarity 
when attempting to understand emotional distress in people who experience 
psychosis.   
 
Negative Affect 
Three studies utilised measures to explore dimensions of negative affect 
such as hostility and generalised distress (Ben-Zeev, Frounfelker, Morris, & 
Corrigan, 2012; Morgades-Bamba, Fuster-Ruizdedapodaca, & Molero, 2019; 
Norman, Windell, Lynch, & Manchanda, 2011). Whilst a consistent 
relationship appears to exist between IS and negative affect, findings from 
longitudinal research studying other aspects of distress suggest that baseline 
distress (e.g. depression) is the main predictor in evolution of distress at later 
timepoints (Pellet et al., 2019).    
 
The implications of these findings is that at present insufficient evidence 
exists for a key element of Wood, Byrne, and Morrison's (2017) cognitive 
model of internalised stigma in psychosis. Although stigmatising appraisals 
and beliefs are hypothesised to hold a bi-directional relationship with 
emotional reactions, evidence appears inconclusive in key expressions of 




It is possible that another underlying mechanism is involved within the 
relationship between self and other knowledge and mood. Results from 
studies such as Valiente et al. (2015) and Murri et al. (2016) indicate that an 
individual's insight may also affect this relationship. This may explain why 
studies have found a correlational association, but interventions have not yet 
observed changes in secondary outcomes such as depression in the 
expected direction. 
 
1.6.1 Limitations and future directions 
This review excluded studies which were not published in English language. 
Findings therefore do not include the four studies identified within systematic 
searching or reflect the potential relationships between IS and distress in 
those geographical areas. Included studies focused upon specific measures 
of distress in the form of depression, anxiety, and shame whilst excluding 
multi-dimensional measures of distress. Although excluding multi-
dimensional measures allowed for the exploration of specific relationships, 
broader expressions of emotional distress out with these categories remain 
unaccounted for.  
 
The definition of 'distress' across different studies affects the interpretation of 
synthesised results. A number of pathways to psychological distress for 
people who experience psychosis have been indentified (Birchwood, 2003) 
and as such, it is increasingly important to recognise this within research 
methodology. However, with few studies investigating the association 
between internalised stigma and distress, it was necessary to include studies 
which did not account for the separate pathways of; distress as intrinsic to 
the experience of psychosis, distress as a response to intrusions, and 
distress as a response to stigmatising diagnosis. It is therefore prudent to be 
mindful that some inconsistency continues to exist when assessing the 




This review also did not include studies which reported upon sub-clinical 
samples. As such it was not possible to report or compare data for individuals 
in different stages of psychosis (i.e. high risk, prodrome, first episode, multi 
episode). It has been suggested (Gerlinger et al., 2013) that individuals may 
have different experiences of stigma at each stage and this may lead to 
differences in internalised stigma cognitions. Further investigation into the 
relationship between internalised stigma and distress for individuals at each 
stage is recommended. 
 
The limitations of this review, and limitations of included studies increasing 
potential risk of bias identified in this review, highlight a number of important 
future directions for research. Although evidence from this review is 
suggestive of a relationship between internalised stigma and distress, 
whether these negative beliefs about the self in relation to others around 
them leads to distress remains inconclusive. To support a developing 
evidence base, researchers may need to continue with careful consideration 
of their study measures so as to reliably capture the potential range of 
participants' experiences of distress. 
 
Although a greater number of studies are using comprehensive and validated 
measures of distress rather than just a one question measure, reliable and 
valid measures to capture a range of expressions of psychological distress 
continue to be under used. Recommendations of this current review echo 
that of Mawson, Cohen, and Berry (2010) and call for interventions to directly 
address distress as a key aim and refinement to protocols. Although this has 
been achieved in part as more recent studies have included secondary 
outcomes, it remains an under investigated or under reported area. Future 
experimental studies may wish to include specific measures of distress, for 
example depression or anxiety, as secondary outcomes when targeting 
cognitive appraisals.  





This systematic review builds on other reviews examining the importance of 
self and social knowledge in the form of internalised stigma for people who 
experience psychosis. A pattern of association between internalised stigma 
and distress in the form of depressive symptoms was found across the 
majority of reviewed studies. However, evidence remains inconclusive 
regarding any association between other possible forms of psychological 
distress. Furthermore, experimental designs that focused on internalised 
stigma did not consistently lead to clinically significant reductions in 
depressive symptoms post treatment. Based on evidence so far, further high 
quality research is recommended to evaluate the efficacy of interventions 
which focus on cognitive appraisals of the self in relation to others as a 
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Objectives. Effective social information processing can help manage the 
potential threat of stigma for those who experience psychosis. This study 
aims to explore the relationship between attachment, reflective functioning, 
cognitive appraisals, and emotional distress in people who experience 
psychosis.  
Design. This study employed a cross-sectional design.   
Methods. Twenty-seven service users completed a questionnaire pack and 
interview examining attachment, emotional distress, reflective functioning, 
cognitive appraisals, and symptomatology. Correlation and multiple 
regression analysis were conducted on the data, with mediation modelling 
used to explore cognitive appraisals as mediatory variables.  
Results. Attachment anxiety was significantly related to cognitive appraisals 
such as personal beliefs about illness, and distress (depression, generalised 
anxiety, social anxiety) but not to reflective functioning. Attachment anxiety 
and cognitive appraisals were found to predict distress including when 
controlling for symptoms of psychosis. Cognitive appraisals were found to 
mediate the relationship between attachment anxiety and emotional distress.  
Conclusions. People with psychosis whose attachment model is of personal 
unworthiness, leading to anxieties about rejection, are likely to experience 
emotional distress. Whilst reflective functioning was not found to influence 
this association, holding negative beliefs about the self in relation to others 
was found to mediate this relationship. Negative appraisals about the self 
and illness may therefore be targeted as potential maintenance factors when 
treating emotional distress in people who experience psychosis.  
 
Keywords: 





 Attachment anxiety is significantly related to emotional distress 
(depression, generalised anxiety, social anxiety). 
 Negative personal beliefs about illness mediated the relationship 
between attachment anxiety and emotional distress in psychosis. 
Individuals with heightened attachment anxiety were more likely to 
experience greater negativity in appraisals relating to shame and 
control. 
 Clinical approaches should consider the potential influence of 
cognitive appraisals about the self in relation to others upon emotional 
distress when formulating service user experiences of psychosis. 
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The mediating role of self and social knowledge between attachment 
and distress in psychosis. 
 
2.3 Introduction 
People with psychosis commonly experience mood disorders such as anxiety 
and depression (Buckley, Miller, Lehrer, & Castle, 2009). High prevalence 
rates of depression in schizophrenia spectrum disorders are reported, with 
estimates around 40% (Upthegrove, Marwaha, & Birchwood, 2017). However 
rates can vary from 20-60% with factors such as stage of illness 
(Upthegrove, Marwaha, & Birchwood, 2017) and cognitive insight (Palmer, 
Gilleen, & David, 2015) influencing figures. Upthegrove (2009) asserted that 
depression in schizophrenia had been a neglected area of the field. This 
assertion was made in the context of evidence that depression is related to 
poor recovery outcomes and increased risk of relapse (an der Heiden, 
Konnecke, Maurer, Ropeter, & Hafner, 2005). In response, research initially 
focused upon depression as a measure of distress. However evidence also 
suggests that different types of anxiety also play a role in the lives of people 
who experience psychosis (Huppert & Smith, 2005).  
 
Hall (2017) argues that the heightened anxiety levels can bias both 
perception and cognition, and is therefore important in understanding 
people's experience of psychosis. Birchwood et al. (2006) suggest that the 
social anxiety experienced by a number of people with psychosis is 
associated with shame appraisals of the diagnosis. Shame appraisals 
hamper emotional recovery from psychosis due to the strong association 
between shame and depression in this population (Keen, George, Scragg, & 
Peters, 2017). This study will build upon the evidence base which has most 
frequently taken depression as a measure of emotional distress by including 
measures of generalised anxiety, and social anxiety.  
Social Mentality Theory (SMT) is considered to be a useful framework for 
understanding a person's adaptation to the experience of psychosis 
58 
 
(MacBeth, Schwannauer, & Gumley, 2008). Similarly, Birchwood et al. (2006) 
comment that receiving a diagnosis of psychosis may be experienced as a 
challenge to an individual's identity due to issues of stigma and social 
desirability. Experiencing such a challenge to current identity might therefore 
lead an individual to adapt their appraisals of the self, including in relation to 
others. This is consistent with the views of Morrison (2001) who emphasised 
that beliefs about cultural acceptability can shape the appraisals people 
make about their anomalous experiences. A diagnosis of psychosis may 
reinforce an individual's beliefs that their experiences are not culturally 
acceptable thus prompting reappraisal of social desirability. 
  
Birchwood (2003) highlighted this process of adaptation as a possible 
pathway to emotional distress. How individuals appraise the personal threat 
of their psychosis diagnosis was proposed to differ by perceptions of shame 
due to stigma and changes in social rank (Birchwood, 2003). This view is 
supported by Iqbal, Birchwood, Chadwick, and Trower (2000) who found that 
participants holding cognitive appraisals that their diagnosis of psychosis had 
enforced a lower social status experienced distress in the form of depression. 
Research suggests that many people with psychosis associate their illness 
status with high levels of shame, blame, and fear of discrimination (Corrigan 
& Watson, 2002; Brohan, Slade, Clement, & Thornicroft, 2010). 
 
Attachment is described by Mikulincer, Shaver, and Pereg (2003) as one of 
the most important conceptual frameworks for understanding how an 
individual regulates their emotions. The attachment system functions to 
monitor and appraise potentially threatening events before activating mental 
representations of strategies to facilitate security with the aim of coping with 
any distress that arises from the threat (Mikulincer, Shaver, & Pereg, 2003). 
These mental representations are hypothesised to become working models 
which guide an individual's attention, interpretations, and predictions about 





Bartholomew and Horowitz (1991) suggest both positive and negative 
models of the self and the other working models can be formed. The 
resultant four attachment styles were then proposed to split across two 
dimensions; attachment anxiety (associated with model of the self) and 
attachment avoidance (associated with model of others). Whilst research has 
traditionally assessed attachment style categorically (eg. secure, insecure-
anxious, insecure-avoidant), evidence suggests that adult attachment can 
fluctuate in the dimensions (Fraley, Vicary, Brumbaugh, & Roisman, 2011). 
To account for these fluctuations, researchers have increasingly assessed 
attachment across the dimensions of anxiety and avoidance. This approach 
has been recommended due to its less restrictive nature (Wickham, Sitko, & 
Bentall, 2014).  
 
Research by Berry, Barrowclough, and Wearden (2008) using the Psychosis 
Attachment Measure (PAM) with participants diagnosed with schizophrenia 
spectrum disorders found that attachment ratings were relatively stable over 
time. Despite this relative stability, they (Berry, Barrowclough, & Wearden, 
2008) reported that changes in the dimension of attachment anxiety were 
positively correlated with changes in symptoms. This finding is supported by 
a more recent systematic review which reported insecure anxious attachment 
to be associated with psychotic symptomatology (Korver-Nieberg, Berry, 
Meijer, & de Haan, 2014). However, it is important to note that this 
association is not unanimous within research, as Pickering, Simpson, and 
Bentall (2008) reported the strength of association reduced after controlling 
for confounders.  
 
A different avenue of research has investigated the potential attachment style 
might hold for predicting distress in people who experience psychosis. This is 
due to the proposed relationship between internal working models and social 
rank through the internalisation of secure attachment where others are 
regarded safe/helpful/supportive, as this means safeness is activated socially 
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(MacBeth, Schwannauer, & Gumley, 2008). Conversely, those with insecure 
attachment may find social rank to be a source of threat, and due to their 
increased focus upon threat, an attentional bias towards issues of social rank 
may be observed (Laithwaite et al., 2009). If an individual perceives their 
diagnosis of psychosis as a threat, the attachment system will be activated 
and their individual working models might be expected to guide that person's 
attention, interpretations, and predictions about the themselves and others.  
 
Mikulincer and Shaver (2012) state there is evidence for an association 
between attachment style and emotional distress. This is further supported 
by a systematic review which reported associations between attachment 
insecurity and depression in people who experience psychosis (Gumley, 
Taylor, Schwannauer, & MacBeth, 2014). It was proposed by Mikulincer and 
Shaver (2012) that the dimension of attachment anxiety is characterised by 
heightened emotional distress. Research utilising this dimensional approach 
reported attachment anxiety was significantly associated with anger (r = 0.37, 
p< 0.001) and depression (r = 0.56, p< 0.001) in a sample group of people 
with psychosis (Darrell-Berry, Bucci, Palmier-Claus, Drake, & Berry, 2017). 
This study seeks to extend current research exploring the relationship 
between attachment anxiety and emotional distress.  
 
Research has also indicated a possible relationship between stigma and 
emotional distress. Wood and Irons (2017) report positive correlations 
between experienced stigma and both depression (r = 0.446, p< 0.01) and 
anxiety (r = 0.474, p< 0.01). Furthermore, the impact of these stigmatising 
experiences on depression was mediated by shame appraisals (Wood & 
Irons, 2017). High levels of stigma around psychosis continues to exist in 
society, with 87% of respondents to a recent report disclosing direct 
experience (Schizophrenia Commission, 2012). It is therefore important to 
investigate the ways in which people process social information about 




One cognitive process which might change an individual's illness appraisals 
around psychosis and therefore the impact of diagnosis itself is reflective 
functioning. Reflective functioning relates to the capacity of an individual to 
understand the mental states of themselves and others, including cognitions 
and affective state (MacBeth, Gumley, Schwannauer, & Fisher, 2011). 
Reflective functioning is argued to develop within the context of secure 
attachment relationships where the individual holds a positive working model 
of both themselves and others (Fonagy et al., 2016). However, if 
environments which offer relational security promote reflective functioning, 
environments which are perceived as interpersonally threatening might 
therefore lead to a reduction in reflective functioning.  
 
Gilbert (2000) argues that emotional expressions of distress such as shame, 
anxiety and depression might be conceptualised as submissive strategies 
when individuals find themselves in position of unwanted low status/social 
rank positions. This is particularly pertinent for people with a diagnosis 
related to psychosis who not only experience stigma but are also reported to 
internalise these experiences (Wood & Irons, 2017). The emotional impact of 
diagnosis might therefore remain stable with additional insight until the 
unwanted social ranking position is cognitively reappraised. 
 
This study aims to build upon current evidence examining the relationship 
between the patterns of how people relate to other people in order to have 
their needs met (attachment style) and forms of emotional distress such as 
anxiety and depression. It will also investigate the thoughts and feelings 
people use about themselves and others to make sense of social situations 
(reflective functioning and cognitive appraisals) as potential mediating 
variables within this relationship. It is hypothesized that: (1) attachment 
anxiety, greater difficulty in reflective functioning, and greater negativity in 
cognitive appraisals of the self in relation to others will be positively 
associated with higher levels of emotional distress; and (2) reflective 
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functioning and cognitive appraisals will mediate the relationship between 




Participants were recruited from secondary care services in Central Scotland, 
United Kingdom. Potential participants were identified and then approached 
by their care coordinator/keyworker from within the Integrated Community 
Mental Health Team and inpatient wards, including rehabilitation wards. 
Inclusion criteria were: (1) a diagnosis related to the symptoms of psychosis 
as determined by the treating clinician; (2) aged 16+; (3) willing to participate 
voluntarily and able to give written informed consent; (4) sufficient 
understanding of English to complete the measures. Participants were 
excluded if they were unable to give informed consent, were unable to 
communicate in English, or had a history of organic factors implicated in the 
aetiology of psychotic symptoms e.g. brain injury. If the potential participant 
consented, they were contacted by the researcher to ask whether they 
wished to participate. 
 
Sample size was calculated according to guidance within Fritz and 
MacKinnon's (2007) article on planning to test mediated effects. Examination 
of previous literature suggested large effect sizes for the attachment-
reflective functioning and attachment-cognitive appraisals. To achieve 0.8 




The self-report version of the Psychosis Attachment Measure (PAM; Berry, 
Wearden, Barrowclough, & Liversidge, 2006) was used as an independent 
variable. It has 16 items, with participants asked to rate each item using a 4-
point scale ranging from ‘not at all’ to ‘very much’. The PAM is based on 
existing measures of attachment along the axes of anxiety and avoidance 
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proposed by Bartholomew and Horowitz (1991). For the purposes of this 
study, only the axis of attachment anxiety was used with higher scores on the 
measure illustrating higher levels of negativity in participants' working model 
of the self. The PAM was found to have an acceptable level of internal 
consistency in this study (Cronbach’s α for both dimensions = 0.67). 
 
Two potential mediator variables were used. The Reflective Functoning 
Questionnaire (RFQ; Fonagy et al., 2016) is an 8-item screening measure of 
reflective functioning. Each item of the measure provides a statement such 
as "I always know what I feel" to which participants are invited to respond 
using a 7-point scale from 'strongly disagree' to 'strongly agree'. The RFQ 
within this study held acceptable reliability and validity (Cronbach's α = 0.67). 
In line with previous studies (eg. Perkins, 2009; Ha, Ensink, Fonagy, & 
Cirino, 2013) a total score was calculated, with higher total scores illustrating 
greater difficulty in reflective functioning.  
 
The Personal Beliefs about Illness Questionnaire – Revised (PBIQ-R; 
Birchwood, Jackson, Brunet, Holden, & Barton, 2012) is a 20-item self-report 
measure designed to reflect current constructs of social rank theory in 
relation to people experiencing psychosis. These five constructs are named 
as; shame, loss, entrapment, control over illness, and social 
marginalization/group fit. The PBIQ-R was found to be internally consistent 
(Cronbach α values for all five subscales between 0.62 and 0.65). In line with 
previous studies (eg. Braehler et al., 2012) a total score was calculated 
alongside subscale scores, with higher scores illustrating less favourable 
beliefs about the self and psychosis. 
 
A composite dependent variable was comprised of three measures of 
emotional distress. This is in acknowledgement of anxiety and depression as 
the most commonly experienced expressions of emotional distress for people 
with psychosis (Buckley, Miller, Lehrer, & Castle, 2009). However research 
also suggests that future choice of anxiety measures should include a 
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measure of social anxiety alongside generalised anxiety as this facet of 
anxiety is more likely to be impacted upon by stigma (Wood & Irons, 2017).  
 
The Generalized Anxiety Disorder Scale (GAD-7; Spitzer, Kroenke, Williams, 
& Lowe, 2006) is a 7-item self-report screening measure designed as a 
diagnostic and to assess symptom severity. Participants are invited to 
respond indicating how often they have been bothered by each of the seven 
itemised problems across four rating points from 'not at all' to 'nearly every 
day'. The Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998) is a 
self-report questionnaire designed to assess generalised fears of social 
interaction. Participants are invited to “indicate the degree to which you feel 
the statement is characteristic or true about you” over a scale of 19 items 
across five rating points from ‘not at all’ to ‘extremely’. The Calgary 
Depression Scale for Schizophrenia (CDSS; Addington, Addington, & 
Schissel, 1990) is a 9-item structured interview which is regularly used within 
research. A total score was calculated, with higher scores illustrating greater 
emotional distress. The distress composite variable was found to have 
acceptable internal consistency for this study (Cronbach's α = 0.77).   
 
A relatively low level of internal consistency is acknowledged. However, 
alpha coefficients for each of the measures were evaluated by taking into 
account this study's specific circumstances. Apart from the RFQ, each 
individual outcome measure was chosen for being well developed and 
validated with a psychosis sample group. Alpha coefficients might therefore 
be better understood in the context of a small sample size and wide variation 
in sample group as later highlighted within study demographics.    
 
2.4.3 Procedure 
This study received approval from an NHS Research Ethics Committee and 
was undertaken as part of the first author's doctoral thesis. A one-off meeting 
was scheduled with those who consented to participate in the study either in 
their own home or at their local mental health service. Written consent was 
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obtained from participants before the questionnaire pack and interview was 
administered by the first author. Participants were given the option of 
completing the questionnaire pack independently or with the support of the 
researcher. Interviews were audio-recorded for the purposes of ensuring 
coding accuracy. 
 
2.4.4 Statistical analysis 
Statistical analyses were conducted using SPSS version 23. All data were 
checked against the assumptions for parametric analysis, and variables were 
found to be normally distributed (except the BCSS Negative Self subscale). 
Pearson correlation coefficients were used to explore the relationships 
between all variables. Linearity was explored with 1 outlier identified and 
removed as it did not meet the threshold in both Cook's distance and 
Leverage values. Mediation models were calculated using the SPSS 
PROCESS macro using Preacher and Hayes' (2004) bootstrap method with 
1000 replications. This bias corrected bootstrap method was selected in 
acknowledgement of the potential for small sample sizes to compromise the 
conclusions drawn from a study. A mediating effect was considered present if 
a statistically significant indirect effect of a mediator was found in the 
relationship between attachment anxiety and distress, or if the strength of 
that relationship reduced when the mediator was introduced. 
 
2.5 Results 
2.5.1 Demographics and clinical characteristics 
A total of 27 participants were recruited and included in the analysis, 9 of 
whom were female and 18 were male with an average age of 44 years (SD, 
13.48: range 21-66). See Table 1 for demographic characteristics of the 
sample. Four further service users were invited to participate by clinicians, of 
which three declined and one was excluded for not meeting diagnosis 
inclusion criteria. All participants had experienced psychotic symptoms, and 




Table 1. Demographics of the study sample 
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Descriptive data for outcome measures can be found in Table 2. The sample 
group reported clinically low PANSS symptomatology with Positive 
(mean=14.89, SD, 5.43: range 9-26), Negative (mean=13.78, SD, 5.07: 
range 9-29), and General Psychopathology (mean=32.30, SD, 9.15: range 
19-55) symptom scores falling below the clinical cut off advised by Kay, 
Opler, and Lindenmayer (1988) for each subscale. The sample group 
reported moderate attachment anxiety (mean=1.46, SD, 0.65: range 0.25-
2.75). However low reflective functioning was reported (mean=1.83, SD, 
0.65: range 0.67-3.50) which is perhaps unexpected when viewed alongside 
the clinically low PANSS symptomatology and moderate levels of attachment 
anxiety reported.  
 
Symptom scores fell just below the clinical cut off scores for generalised 
anxiety (mean=8.78, SD, 5.98: range 0-20) and social anxiety (mean=27.37, 
SD, 15.13: range 1-60), however above the clinical cut off for depression 
(mean=7.81, SD, 5.68: range 0-22).  The PBIQ-R total scores reported 
(mean=49.26, SD, 10.11: range 24-68) are in line with scores reported for a 
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first episode psychosis sample group with clinical levels of depression 
(Birchwood, Jackson, Brunet, Holden, & Barton, 2012). The wide range of  
scores is of note and may reflect variations in the sample stage of illness. 
Table 2. Descriptive data for all outcome measures 
Note. SD = Standard Deviation; PAM = Psychosis Attachment Measure; PBIQ-R = 
Personal Beliefs about Illness Questionnaire-Revised; PANSS = Positive and 
Negative Syndrome Scale combined symptom scores; RFQ8 = Reflective 
Functioning Questionnaire; GAD = Generalised Anxiety Disorder Questionnaire; 
SIAS = Social Interaction Anxiety Scale; CDSS = Calgary Depression for 
Schizophrenia Scale. 
 
2.5.2 Predictors of emotional distress hypothesis 
Pearson correlation coefficients (see Table 3) illustrated that the key 
variables of attachment anxiety, PBIQ-R, and distress were significantly 
related to one another. Attachment anxiety was strongly positively correlated 
with the PBIQ-R total, and Distress variables. Attachment avoidance was 
also significantly associated with the composite variable of distress and with 
the PBIQ-R, holding particularly strong positive associations with the 
subscales of Shame and Control.  
 
PBIQ-R subscales of Shame, Loss, and Control were also strongly positively 
correlated with distress. Reflective functioning was not significantly related to 
other mediator (PBIQ-R) or outcome (distress) variables and was therefore 
not included within mediation analysis. 









































PANSS 28.67 7.70 19 51 



























*** Correlation is significant at the alpha corrected level (2-tailed), 
** Correlation is significant at the 0.01 level (2-tailed), * Correlation is significant at the 0.05 level (2-tailed). 
 
Note. PAM = Psychosis Attachment Measure; PBIQ-R = Personal Beliefs about Illness Questionnaire-Revised; BCSS NS = Brief Core 
Schema Scale Negative Self; RFQ8 = Reflective Functioning Questionnaire; GAD = Generalised Anxiety Disorder Questionnaire; SIAS = 
Social Interaction Anxiety Scale; CDSS = Calgary Depression for Schizophrenia Scale. 
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1. PAM Anxiety 
2. PAM Avoidance 
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9. PANSS -.009 -.118 -.348 -.425* -.226 -.225 -.301 -.160        
10. RFQ8 -.212 -.093 .165 .021 .171 .234 .134 .085 .072       

























































15. Age .187 .122 .027 .043 -.086 .159 -.002 -.010 .068 -.080 .047 .077 -.083 .329  
16. Gender .108 .023 .108 .233 -.044 .306 .054 -.142 -.406* .055 .172 .187 .125 .164 .489*** 
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Age, gender, and PANSS symptom scores were examined as a potential 
confounding variable in relation to the main study variables. There were no 
significant correlations between age, gender, or PANSS symptom scores 
with attachment anxiety, reflective functioning, or distress. Furthermore, the 
combined PANSS positive and negative symptom scores were not correlated 
with any variables other than shame from the PBIQ-R. Due to the significant 
association identified, PANSS symptoms were controlled for within 
exploratory mediation analysis where PBIQ-Shame was entered as a 
potential mediator.  
 
2.5.3 Mediation analysis 
Results from mediation analysis showed attachment anxiety exerted a 
significant effect on emotional distress indirectly through personal beliefs 
about illness (see Figure 1). The 'a' path (attachment anxiety-personal beliefs 
about illness) and 'b' path (personal beliefs about illness-emotional distress) 
were both found to be significant (a = 8.40, p=0.0089; b = 1.27, p=0.0009). A 
bias-corrected bootstrap confidence interval for the indirect effect (path 'ab' = 
24.47, p=0.0005) did not contain zero (2.10-25.30). The direct effect of 
attachment anxiety on emotional distress (c' path) remained significant (c' = 
13.70, p=0.0226). This model (including predictor variables) explained 
40.38% of the variance in emotional distress. 
 




2.5.4 Exploratory analysis 
The PBIQ-R subscale scores were then explored as potential mediators 
between attachment anxiety and emotional distress whilst controlling for 
PANSS symptom scores. Multiple mediation analyses showed that 
attachment anxiety exerted a significant indirect effect on emotional distress 
through the PBIQ-R subscales of shame and control (see Figure 2). When 
exploring the subscales of loss, entrapment, and social marginalisation were 
not found to mediate the relationship between attachment and distress. 
However it is important to note that this small sample size is likely to produce 
an overestimate in model variance. It is therefore recommended these results 
are viewed with caution until replication with a larger sample. 
 
 
Figure 2. Results of exploratory analyses with PBIQ-R subscales of 
shame, loss, entrapment, control, and social marginalisation entered as 





The 'a' path (attachment anxiety-shame) and the 'b' path (shame-emotional 
distress) were both found to be significant (a = 2.17, p=0.0041; b = 4.38, 
p=0.0089). A bias-corrected bootstrap confidence interval for the indirect 
effect (path 'ab' = 19.11, p=0.0038) did not contain zero (6.78-31.44). The 
direct effect of attachment anxiety on emotional distress (c' path) did not 
remain significant (c' = 9.61, p=0.1369). This model (including predictor 
variables) explained 28.97% of the variance in emotional distress. 
 
Control: 
The 'a' path (attachment anxiety-control) was found to be significant (a = 
2.64, p=0.0015) but the 'b' path (control-emotional distress) was not (b = 
0.72, p=0.6667). A bias-corrected bootstrap confidence interval for the 
indirect effect (path 'ab' = 19.11, p=0.0038) did not contain zero (6.78-31.44). 
The direct effect of attachment anxiety on emotional distress (c' path) did not 
remain significant (c' = 8.61, p=0.2001). 
 
2.6 Discussion 
The study aimed to explore the relationship between attachment, reflective 
functioning, cognitive appraisals, and emotional distress in people who 
experience psychosis. This first hypothesis was partially supported with 
attachment anxiety, cognitive appraisals of the self in relation to others, and 
emotional distress significantly related. The significant relationships found 
between these variables is supported by previous literature  (Birchwood et 
al., 2006; Darrell-Berry, Bucci, Palmier-Claus, Drake, & Berry, 2017; Gumley, 
Taylor, Schwannauer, & MacBeth, 2014; Iqbal, Birchwood, Chadwick, & 
Trower, 2000).  
 
However a relationship was not found between reflective functioning and 
either attachment anxiety or any measures of distress, and so hypothesis 
one was not fully supported. The lack of association found between reflective 
functioning and distress is surprising given that those with greater capacity 
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for reflective functioning are suggested to be better able to understand their 
own affective state (MacBeth, Gumley, Schwannauer, & Fisher, 2011). 
Findings from this study suggesting reduced capacity for reflective 
functioning is not associated with distress therefore appears to stand in 
contrast with previous research on reflective functioning in psychosis. 
 
Whilst literature (eg Fonagy, Gergely, Jurist, & Target, 2002) suggests 
associations between attachment and reflective functioning, previous 
reporting upon this relationship in psychosis has highlighted inconsistencies. 
For example, research which organised attachment classifications 
categorically, found significant differences in reflective functioning for the 
insecure dismissing but not insecure preoccupied groups (MacBeth, Gumley, 
Schwannauer, & Fisher, 2011). From a dimensional approach, this finding 
suggests that significant differences in reflective functioning exist for people 
who express high attachment avoidance but not in those expressing high 
attachment anxiety. If reflective functioning develops within the context of 
secure attachment as Fonagy et al. (2016) propose, then a more consistent 
relationship between reflective functioning and the dimensions of both 
attachment anxiety and avoidance might be expected. It is also of note that 
whilst the RFQ8 was validated for use with clinical sample groups, it had not 
yet been utilised with people who experience psychosis and may not be as 
well suited to this clinical group. 
 
The study found a stronger positive association between emotional distress 
and attachment anxiety than attachment avoidance. Although attachment 
avoidance was significantly associated with the composite variable of 
distress, this appears to be reflecting scores in generalised anxiety rather 
than across all three scales.  Despite this, evidence suggests that attachment 
insecurity, whether high avoidance or high anxiety, is also associated with 
difficulties in regulating emotions (Mikulincer & Shaver, 2019). Findings may 
therefore reflect differences in emotion regulation strategies rather than 
emotional expression. This is consistent with the theory that those reporting 
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high attachment avoidance deactivate the attachment system and avoid 
emotional expression as others are perceived negatively (Carnelley, Otway, 
& Rowe, 2016).  
 
Previous exploration of associations between attachment style and distress 
in psychosis reported both attachment anxiety and avoidance predicting 
anxiety and depression (MacBeth, Schwannauer, & Gumley, 2008). It is 
inconsistencies such as this in the evidence base that led Carnelley, Otway, 
and Rowe (2016) to explore relationships between the dimensions of 
attachment (anxiety and avoidance) and mood (anxiety and depression). 
Through the use of an attachment priming design, Carnelley, Otway, and 
Rowe (2016) concluded that whilst attachment insecurity in general is 
associated with emotional distress, the relationship between anxiety and 
depression with attachment anxiety is perhaps more reliable. 
 
No significant relationship was observed between PANSS symptom severity 
and emotional distress. This finding is surprising as the association between 
anxiety and depression with severity of psychotic symptomatology has been 
observed through systematic review (Hartley, Barrowclough, & Haddock, 
2013). This result may be linked to the previously mentioned clinical 
characteristics of the sample group where symptom scores lay below clinical 
cut off values. Findings may also reflect the small sample size which varied 
widely in current PANSS symptom severity due to being drawn from 
community, rehab, and acute settings. Whilst a chronic population drawn 
from community settings may not be symptomatic and are thus not a group 
who are high in expressed emotion, those participants from acute settings 
may present with a different symptom and emotion profile. The stage of 
illness and phase of disorder is therefore an important issue which future 
studies may attend to in further detail. Although limitations in sample size 
mean it is necessary to draw only tentative conclusions, this study appears to 
support Birchwood's (2003) proposed theory of three overlapping pathways 
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to distress in psychosis rather than a singular pathway of distress being 
intrinsic to psychosis.  
 
The second hypothesis was also partially supported. Reflective functioning 
was not further explored as a potential mediator due to lack of association 
with the other key variables of attachment anxiety and distress. Nevertheless, 
cognitive appraisals (PBIQ-R) mediated the relationship between attachment 
anxiety and emotional distress. This provides further support for the use of 
SMT in explaining one of Birchwood's (2003) three pathways to distress. 
Receiving a stigmatising diagnosis may represent a 'threat' and subsequent 
negative evaluation of one's own social ranking in comparison to others after 
experiencing psychosis may lead to increased emotional distress.  
 
Findings suggest that greater negativity in PBIQ-R scores increases the level 
of distress, particularly for those with greater attachment anxiety. The 
mediation model highlights cognitive appraisals such as perceptions of 
shame and loss of control as potential influential factors in emotional distress 
for people who experience psychosis. These findings might also help to 
explain the variation in emotional distress experienced by those who have 
greater levels of attachment anxiety.  
 
2.6.1 Clinical Implications 
This study has clinical implications as findings suggest the importance of 
exploring self and other cognitive appraisals when working with service users 
who have experienced psychosis. The role of shame cognitions and recovery 
implications have recently been highlighted in literature for people who 
experience psychosis (Keen, George, Scragg, & Peters, 2017). Whilst the 
importance of attending to shame appraisals is also highlighted in this study's 





Although controlled trials of interventions designed to target shame-based 
cognitions are increasingly being developed (e.g. Morrison et al., 2016; 
Wood, Byrne, Enache, & Morrison, 2018), primary outcomes have not 
focused upon measures of distress. This study provides tentative evidence 
for exploring the potential of cognitive interventions targeting shame and 
control based cognitions when working to reduce emotional distress. It is 
hoped that greater understanding of key cognitions influencing emotional 
distress for people with psychosis will enable researchers to refine their 
interventions in the future. Furthermore, researchers developing interventions 
may seek to further investigate emotional distress as a key outcome.  
 
2.6.2 Limitations of the study 
This study encountered a number of limitations. Firstly, recruitment was 
reliant upon referrals from care co-ordinators/keyworkers, and clinicians may 
have been reluctant to approach service users who they perceived as 
unlikely to participate or more unwell despite capacity to consent to research. 
This 'screening' of potential participants may have led to sampling bias.  
Additional confounding variables such as neurocognition may have been 
present. Evidence suggests there is an association between neurocognitive 
impairments (e.g. in the domains of abstraction, memory, and attention) and 
negative appraisals about the self such as defeatist beliefs (Grant & Beck, 
2008). Whilst the average age of study participants was 44, the average age 
of onset was 25 with some participants reporting symptom onset age 16. The 
possible long-term exposure to antipsychotic medication means that there is 
potential for this to exert a negative effect upon cognitive functioning (Husa et 
al., 2017). This factor may therefore have influenced PBIQ-R scores as a 
confounding variable in the study.  
 
The study was also limited by the small sample size. As previously noted, it is 
possible that small sample size led to findings such as lack of association 
between psychotic symptomatology and distress. Although steps such as 
bootstrapping of data were taken in a attempt to mitigate this issue, it is 
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recognised that a larger sample size would reduce the risk of Type II errors, 
especially given the potential range of illness stages. Future studies with 
larger sample sizes may further investigate cognitive appraisals with greater 
appreciation of different illness stages. Finally, the study did not account for 
differences in emotional regulation as a potential confounding variable when 
measuring expression of emotional distress. It is therefore recommended that 
future studies explore difficulties in emotion regulation and control for this 
potential confounding variable if required.  
 
2.6.3 Conclusions 
This study explored the relationship between self and social knowledge and 
emotional distress in psychosis. It identifies a pathway from attachment 
anxiety to distress through personal beliefs about illness. Greater negativity 
in personal beliefs about illness may lead to increased expression of 
emotional distress. It is hoped that future research will continue to explore the 
factors influencing the levels of emotional distress experienced by people 
with psychosis whilst developing increasingly efficacious interventions to 
support people in their recovery throughout the course of illness. 
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Elsevier will ensure, at no additional charge, that these figures will appear in 
color online (e.g., ScienceDirect and other sites) regardless of whether or not 
these illustrations are reproduced in color in the printed version. For color 
reproduction in print, you will receive information regarding the costs 
from Elsevier after receipt of your accepted article. Please indicate your 
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preference for color: in print or online only. Further information on the 
preparation of electronic artwork. 
Figure captions  
Ensure that each illustration has a caption. Supply captions separately, not 
attached to the figure. A caption should comprise a brief title (not on the 
figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used. 
Tables  
 
Please submit tables as editable text and not as images. Tables can be 
placed either next to the relevant text in the article, or on separate page(s) at 
the end. Number tables consecutively in accordance with their appearance in 
the text and place any table notes below the table body. Be sparing in the 
use of tables and ensure that the data presented in them do not duplicate 
results described elsewhere in the article. Please avoid using vertical rules 
and shading in table cells. 
References  
Citations in the text should follow the referencing style used by the American 
Psychological Association. You are referred to the Publication Manual of the 
American Psychological Association, Sixth Edition, ISBN 1-4338-0559-6, 
copies of which may be ordered from 
http://books.apa.org/books.cfm?id=4200067 or APA Order Dept., P.O.B. 
2710, Hyattsville, MD 20784, USA or APA, 3 Henrietta Street, London, 
WC3E 8LU, UK. Details concerning this referencing style can also be found 
at http://humanities.byu.edu/linguistics/Henrichsen/APA/APA01.html 
Citation in text  
Please ensure that every reference cited in the text is also present in the 
reference list (and vice versa). Any references cited in the abstract must be 
given in full. Unpublished results and personal communications are not 
recommended in the reference list, but may be mentioned in the text. If these 
references are included in the reference list they should follow the standard 
reference style of the journal and should include a substitution of the 
publication date with either 'Unpublished results' or 'Personal 
communication'. Citation of a reference as 'in press' implies that the item has 
been accepted for publication. 
Web references  
As a minimum, the full URL should be given and the date when the reference 
was last accessed. Any further information, if known (DOI, author names, 
dates, reference to a source publication, etc.), should also be given. Web 
references can be listed separately (e.g., after the reference list) under a 
different heading if desired, or can be included in the reference list. 
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Data references  
This journal encourages you to cite underlying or relevant datasets in your 
manuscript by citing them in your text and including a data reference in your 
Reference List. Data references should include the following elements: 
author name(s), dataset title, data repository, version (where available), year, 
and global persistent identifier. Add [dataset] immediately before the 
reference so we can properly identify it as a data reference. The [dataset] 
identifier will not appear in your published article. 
References in a special issue  
Please ensure that the words 'this issue' are added to any references in the 
list (and any citations in the text) to other articles in the same Special Issue. 
Reference management software  
Most Elsevier journals have their reference template available in many of the 
most popular reference management software products. These include all 
products that support Citation Style Language styles, such as Mendeley. 
Using citation plug-ins from these products, authors only need to select the 
appropriate journal template when preparing their article, after which citations 
and bibliographies will be automatically formatted in the journal's style. If no 
template is yet available for this journal, please follow the format of the 
sample references and citations as shown in this Guide. If you use reference 
management software, please ensure that you remove all field codes before 
submitting the electronic manuscript. More information on how to remove 
field codes from different reference management software. 
 
Users of Mendeley Desktop can easily install the reference style for this 
journal by clicking the following link: 
http://open.mendeley.com/use-citation-style/clinical-psychology-review 
When preparing your manuscript, you will then be able to select this style 
using the Mendeley plug-ins for Microsoft Word or LibreOffice. 
Reference style  
References should be arranged first alphabetically and then further sorted 
chronologically if necessary. More than one reference from the same 
author(s) in the same year must be identified by the letters "a", "b", "c", etc., 
placed after the year of publication. References should be formatted with a 
hanging indent (i.e., the first line of each reference is flush left while the 
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3. Manuscript Categories and Requirements 
4. Preparing the Submission 
5. Editorial Policies and Ethical Considerations 
6. Author Licensing 
7. Publication Process After Acceptance 
8. Post Publication 
9. Editorial Office Contact Details 
1. SUBMISSION 
Authors should kindly note that submission implies that the content has not 
been published or submitted for publication elsewhere except as a brief 
abstract in the proceedings of a scientific meeting or symposium. 
Once the submission materials have been prepared in accordance with 
the Author Guidelines, manuscripts should be submitted online at 
http://www.editorialmanager.com/paptrap 
Click here for more details on how to use Editorial Manager. 
All papers published in the Psychology and Psychotherapy: Theory Research 
and Practice are eligible for Panel A: Psychology, Psychiatry and 
Neuroscience in the Research Excellence Framework (REF). 
Data protection: 
By submitting a manuscript to or reviewing for this publication, your name, 
email address, and affiliation, and other contact details the publication might 
require, will be used for the regular operations of the publication, including, 
when necessary, sharing with the publisher (Wiley) and partners for 
production and publication. The publication and the publisher recognize the 
importance of protecting the personal information collected from users in the 
operation of these services, and have practices in place to ensure that steps 
are taken to maintain the security, integrity, and privacy of the personal data 
collected and processed. You can learn more at 
https://authorservices.wiley.com/statements/data-protection-policy.html. 
Preprint policy:  
This journal will consider for review articles previously available as preprints 
on non-commercial servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, 
engrXiv, etc. Authors may also post the submitted version of a manuscript to 
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non-commercial servers at any time. Authors are requested to update any 
pre-publication versions with a link to the final published article. 
 
2. AIMS AND SCOPE 
Psychology and Psychotherapy: Theory Research and Practice is an 
international scientific journal with a focus on the psychological aspects of 
mental health difficulties and well-being; and psychological problems and 
their psychological treatments. We welcome submissions from mental health 
professionals and researchers from all relevant professional backgrounds. 
The Journal welcomes submissions of original high quality empirical research 
and rigorous theoretical papers of any theoretical provenance provided they 
have a bearing upon vulnerability to, adjustment to, assessment of, and 
recovery (assisted or otherwise) from psychological disorders. Submission of 
systematic reviews and other research reports which support evidence-based 
practice are also welcomed, as are relevant high quality analogue studies 
and Registered Reports. The Journal thus aims to promote theoretical and 
research developments in the understanding of cognitive and emotional 
factors in psychological disorders, interpersonal attitudes, behaviour and 
relationships, and psychological therapies (including both process and 
outcome research) where mental health is concerned. Clinical or case 
studies will not normally be considered except where they illustrate 
particularly unusual forms of psychopathology or innovative forms of therapy 
and meet scientific criteria through appropriate use of single case 
experimental designs. 
All papers published in Psychology and Psychotherapy: Theory, Research 
and Practice are eligible for Panel A: Psychology, Psychiatry and 
Neuroscience in the Research Excellence Framework (REF). 
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS 
 Articles should adhere to the stated word limit for the particular article 
type. The word limit excludes the abstract, reference list, tables and 
figures, but includes appendices. 
Word limits for specific article types are as follows: 
 Research articles: 5000 words 
 Qualitative papers: 6000 words 
 Review papers: 6000 words 
 Special Issue papers: 5000 words 
In exceptional cases the Editor retains discretion to publish papers beyond 
this length where the clear and concise expression of the scientific content 
requires greater length (e.g., explanation of a new theory or a substantially 
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new method). Authors must contact the Editor prior to submission in such a 
case. 
 Please refer to the separate guidelines for Registered Reports. 
All systematic reviews must be pre-registered. 
4. PREPARING THE SUBMISSION 




Cover letters are not mandatory; however, they may be supplied at the 
author’s discretion. They should be pasted into the ‘Comments’ box in 
Editorial Manager. 
Parts of the Manuscript 
The manuscript should be submitted in separate files: title page; main text 
file; figures/tables; supporting information. 
Title Page 
You may like to use this template for your title page. The title page should 
contain: 
 A short informative title containing the major key words. The title 
should not contain abbreviations (see Wiley's best practice SEO tips); 
 A short running title of less than 40 characters; 
 The full names of the authors; 
 The author's institutional affiliations where the work was conducted, 
with a footnote for the author’s present address if different from where 
the work was conducted; 
 Abstract; 
 Keywords; 
 Practitioner Points; 
 Acknowledgments. 
Authorship 
Please refer to the journal’s Authorship policy in the Editorial Policies and 
Ethical Considerations section for details on author listing eligibility. When 
entering the author names into Editorial Manager, the corresponding author 
will be asked to provide a CRediT contributor role to classify the role that 
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each author played in creating the manuscript. Please see the Project 
CRediT website for a list of roles. 
Abstract 
Please provide an abstract of up to 250 words, giving a concise statement of 
the intention, results or conclusions of the article. 
Articles containing original scientific research should include the headings: 
Objectives, Design, Methods, Results, Conclusions. Review articles should 
use the headings: Purpose, Methods, Results, Conclusions. 
Keywords 
Please provide appropriate keywords. 
Practitioner Points 
All articles must include Practitioner Points – these are 2-4 bullet points, 
following the abstract, with the heading ‘Practitioner Points’. These should 
briefly and clearly outline the relevance of your research to professional 
practice. (Please include the 'Practitioner Points' in your main document but 
do not submit them to Editorial Manager with your abstract.) 
Acknowledgments 
Contributions from anyone who does not meet the criteria for authorship 
should be listed, with permission from the contributor, in an 
Acknowledgments section. Financial and material support should also be 
mentioned. Thanks to anonymous reviewers are not appropriate. 
Main Text File 
As papers are double-blind peer reviewed, the main text file should not 
include any information that might identify the authors. 
The main text file should be presented in the following order: 
 Title 
 Main text 
 References 
 Tables and figures (each complete with title and footnotes) 
 Appendices (if relevant) 
Supporting information should be supplied as separate files. Tables and 
figures can be included at the end of the main document or attached as 
separate files but they must be mentioned in the text. 
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 As papers are double-blind peer reviewed, the main text file should not 
include any information that might identify the authors. Please do not 
mention the authors’ names or affiliations and always refer to any 
previous work in the third person. 
 The journal uses British/US spelling; however, authors may submit 
using either option, as spelling of accepted papers is converted during 
the production process. 
References 
References should be prepared according to the Publication Manual of the 
American Psychological Association (6th edition). This means in text citations 
should follow the author-date method whereby the author's last name and the 
year of publication for the source should appear in the text, for example, 
(Jones, 1998). The complete reference list should appear alphabetically by 
name at the end of the paper. Please note that for journal articles, issue 
numbers are not included unless each issue in the volume begins with page 
1, and a DOI should be provided for all references where available. 
For more information about APA referencing style, please refer to the APA 
FAQ. 
Reference examples follow: 
Journal article 
Beers, S. R. , & De Bellis, M. D. (2002). Neuropsychological function in 
children with maltreatment-related posttraumatic stress disorder. The 
American Journal of Psychiatry, 159, 483–486. 
doi:10.1176/appi.ajp.159.3.483 
Book 
Bradley-Johnson, S. (1994). Psychoeducational assessment of students who 
are visually impaired or blind: Infancy through high school (2nd ed.). Austin, 
TX: Pro-ed. 
Internet Document 
Norton, R. (2006, November 4). How to train a cat to operate a light switch 
[Video file]. Retrieved from http://www.youtube.com/watch?v=Vja83KLQXZs 
Tables 
Tables should be self-contained and complement, not duplicate, information 
contained in the text. They should be supplied as editable files, not pasted as 
images. Legends should be concise but comprehensive – the table, legend, 
and footnotes must be understandable without reference to the text. All 
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abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, 
should be used (in that order) and *, **, *** should be reserved for P-values. 
Statistical measures such as SD or SEM should be identified in the headings. 
Figures 
Although authors are encouraged to send the highest-quality figures 
possible, for peer-review purposes, a wide variety of formats, sizes, and 
resolutions are accepted. 
Click here for the basic figure requirements for figures submitted with 
manuscripts for initial peer review, as well as the more detailed post-
acceptance figure requirements. 
Legends should be concise but comprehensive – the figure and its legend 
must be understandable without reference to the text. Include definitions of 
any symbols used and define/explain all abbreviations and units of 
measurement. 
Colour figures. Figures submitted in colour may be reproduced in colour 
online free of charge. Please note, however, that it is preferable that line 
figures (e.g. graphs and charts) are supplied in black and white so that they 
are legible if printed by a reader in black and white. If an author would prefer 
to have figures printed in colour in hard copies of the journal, a fee will be 
charged by the Publisher. 
Supporting Information 
Supporting information is information that is not essential to the article, but 
provides greater depth and background. It is hosted online and appears 
without editing or typesetting. It may include tables, figures, videos, datasets, 
etc. 
Click here for Wiley’s FAQs on supporting information. 
Note: if data, scripts, or other artefacts used to generate the analyses 
presented in the paper are available via a publicly available data repository, 
authors should include a reference to the location of the material within their 
paper. 
General Style Points 
For guidelines on editorial style, please consult the APA Publication 
Manual published by the American Psychological Association. The following 
points provide general advice on formatting and style. 
 Language: Authors must avoid the use of sexist or any other 
discriminatory language. 
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 Abbreviations: In general, terms should not be abbreviated unless 
they are used repeatedly and the abbreviation is helpful to the reader. 
Initially, use the word in full, followed by the abbreviation in 
parentheses. Thereafter use the abbreviation only. 
 Units of measurement: Measurements should be given in SI or SI-
derived units. Visit the Bureau International des Poids et Mesures 
(BIPM) website for more information about SI units. 
 Effect size: In normal circumstances, effect size should be 
incorporated. 
 Numbers: numbers under 10 are spelt out, except for: measurements 
with a unit (8mmol/l); age (6 weeks old), or lists with other numbers 
(11 dogs, 9 cats, 4 gerbils). 
Wiley Author Resources 
Manuscript Preparation Tips: Wiley has a range of resources for authors 
preparing manuscripts for submission available here. In particular, we 
encourage authors to consult Wiley’s best practice tips on Writing for Search 
Engine Optimization. 
Editing, Translation, and Formatting Support: Wiley Editing Services can 
greatly improve the chances of a manuscript being accepted. Offering expert 
help in English language editing, translation, manuscript formatting, and 
figure preparation, Wiley Editing Services ensures that the manuscript is 
ready for submission. 
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS 
Peer Review and Acceptance 
Except where otherwise stated, the journal operates a policy of anonymous 
(double blind) peer review. Please ensure that any information which may 
reveal author identity is blinded in your submission, such as institutional 
affiliations, geographical location or references to unpublished research. We 
also operate a triage process in which submissions that are out of scope or 
otherwise inappropriate will be rejected by the editors without external peer 
review. The qualitative guidelines explain how the quality of research papers 
using qualitative methods will be judged. Before submitting, please read the 
terms and conditions of submission and the declaration of competing 
interests. 
We aim to provide authors with a first decision within 90 days of submission. 
Further information about the process of peer review and production can be 
found in ‘What happens to my paper?’ Appeals are handled according to 
the procedure recommended by COPE. Wiley's policy on the confidentiality 
of the review process is available here. 
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Clinical Trial Registration 
The journal requires that clinical trials are prospectively registered in a 
publicly accessible database and clinical trial registration numbers should be 
included in all papers that report their results. Authors are asked to include 
the name of the trial register and the clinical trial registration number at the 
end of the abstract. If the trial is not registered, or was registered 
retrospectively, the reasons for this should be explained. 
Research Reporting Guidelines 
Accurate and complete reporting enables readers to fully appraise research, 
replicate it, and use it. Authors are encouraged to adhere to recognised 
research reporting standards. 
We also encourage authors to refer to and follow guidelines from: 
 Future of Research Communications and e-Scholarship (FORCE11) 
 The Gold Standard Publication Checklist from Hooijmans and 
colleagues 
 FAIRsharing website 
Conflict of Interest 
The journal requires that all authors disclose any potential sources of conflict 
of interest. Any interest or relationship, financial or otherwise that might be 
perceived as influencing an author's objectivity is considered a potential 
source of conflict of interest. These must be disclosed when directly relevant 
or directly related to the work that the authors describe in their manuscript. 
Potential sources of conflict of interest include, but are not limited to: patent 
or stock ownership, membership of a company board of directors, 
membership of an advisory board or committee for a company, and 
consultancy for or receipt of speaker's fees from a company. The existence 
of a conflict of interest does not preclude publication. If the authors have no 
conflict of interest to declare, they must also state this at submission. It is the 
responsibility of the corresponding author to review this policy with all authors 
and collectively to disclose with the submission ALL pertinent commercial 
and other relationships. 
Funding 
Authors should list all funding sources in the Acknowledgments section. 
Authors are responsible for the accuracy of their funder designation. If in 
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All listed authors should have contributed to the manuscript substantially and 
have agreed to the final submitted version. Authorship is defined by the 
criteria set out in the APA Publication Manual: 
“Individuals should only take authorship credit for work they have actually 
performed or to which they have substantially contributed (APA Ethics Code 
Standard 8.12a, Publication Credit). Authorship encompasses, therefore, not 
only those who do the actual writing but also those who have made 
substantial scientific contributions to a study. Substantial professional 
contributions may include formulating the problem or hypothesis, structuring 
the experimental design, organizing and conducting the statistical analysis, 
interpreting the results, or writing a major portion of the paper. Those who so 
contribute are listed in the byline.” (p.18) 
Data Sharing and Data Accessibility 
Psychology and Psychotherapy: Theory, Research and Practice recognizes 
the many benefits of archiving data for scientific progress. Archived data 
provides an indispensable resource for the scientific community, making 
possible future replications and secondary analyses, in addition to the 
importance of verifying the dependability of published research findings. 
The journal expects that where possible all data supporting the results in 
papers published are archived in an appropriate public archive offering open 
access and guaranteed preservation. The archived data must allow each 
result in the published paper to be recreated and the analyses reported in the 
paper to be replicated in full to support the conclusions made. Authors are 
welcome to archive more than this, but not less. 
All papers need to be supported by a data archiving statement and the data 
set must be cited in the Methods section. The paper must include a link to the 
repository in order that the statement can be published. 
It is not necessary to make data publicly available at the point of submission, 
but an active link must be included in the final accepted manuscript. For 
authors who have pre-registered studies, please use the Registered Report 
link in the Author Guidelines. 
In some cases, despite the authors’ best efforts, some or all data or materials 
cannot be shared for legal or ethical reasons, including issues of author 
consent, third party rights, institutional or national regulations or laws, or the 
nature of data gathered. In such cases, authors must inform the editors at the 
time of submission. It is understood that in some cases access will be 
provided under restrictions to protect confidential or proprietary information. 
Editors may grant exceptions to data access requirements provided authors 
explain the restrictions on the data set and how they preclude public access, 
and, if possible, describe the steps others should follow to gain access to the 
data. 
 
116 of 156 
 
 
If the authors cannot or do not intend to make the data publicly available, a 
statement to this effect, along with the reasons that the data is not shared, 
must be included in the manuscript. 
Finally, if submitting authors have any questions about the data sharing 
policy, please access the FAQs for additional detail. 
Publication Ethics 
This journal is a member of the Committee on Publication Ethics (COPE). 
Note this journal uses iThenticate’s CrossCheck software to detect instances 
of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 
10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics 
Guidelines can be found here. 
ORCID 
As part of the journal’s commitment to supporting authors at every step of the 
publishing process, the journal requires the submitting author (only) to 
provide an ORCID iD when submitting a manuscript. This takes around 2 
minutes to complete. Find more information here. 
6. AUTHOR LICENSING 
If a paper is accepted for publication, the author identified as the formal 
corresponding author will receive an email prompting them to log in to Author 
Services, where via the Wiley Author Licensing Service (WALS) they will be 
required to complete a copyright license agreement on behalf of all authors of 
the paper. 
Authors may choose to publish under the terms of the journal’s standard 
copyright agreement, or OnlineOpen under the terms of a Creative Commons 
License. 
General information regarding licensing and copyright is available here. To 
review the Creative Commons License options offered under OnlineOpen, 
please click here. (Note that certain funders mandate a particular type of CC 
license be used; to check this please click here.) 
BPS members: 
Self-Archiving Definitions and Policies: Note that the journal’s standard 
copyright agreement allows for self-archiving of different versions of the 
article under specific conditions. Please click here for more detailed 
information about self-archiving definitions and policies. 
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Open Access fees: Authors who choose to publish using OnlineOpen will be 
charged a fee. A list of Article Publication Charges for Wiley journals is 
available here. 
Funder Open Access: Please click here for more information on Wiley’s 
compliance with specific Funder Open Access Policies. 
7. PUBLICATION PROCESS AFTER ACCEPTANCE 
Accepted Article Received in Production 
When an accepted article is received by Wiley’s production team, the 
corresponding author will receive an email asking them to login or register 
with Wiley Author Services. The author will be asked to sign a publication 
license at this point. 
Proofs 
Once the paper is typeset, the author will receive an email notification with 
full instructions on how to provide proof corrections. 
Please note that the author is responsible for all statements made in their 
work, including changes made during the editorial process – authors should 
check proofs carefully. Note that proofs should be returned within 48 hours 
from receipt of first proof. 
Publication Charges 
Colour figures. Colour figures may be published online free of charge; 
however, the journal charges for publishing figures in colour in print. If the 
author supplies colour figures, they will be sent a Colour Work Agreement 
once the accepted paper moves to the production process. If the Colour 
Work Agreement is not returned by the specified date, figures will be 
converted to black and white for print publication. 
Early View 
The journal offers rapid publication via Wiley’s Early View service. Early View 
(Online Version of Record) articles are published on Wiley Online Library 
before inclusion in an issue. Before we can publish an article, we require a 
signed license (authors should login or register with Wiley Author Services). 
Once the article is published on Early View, no further changes to the article 
are possible. The Early View article is fully citable and carries an online 
publication date and DOI for citations. 
8. POST PUBLICATION 
Access and Sharing 
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When the article is published online:  
 The author receives an email alert (if requested). 
 The link to the published article can be shared through social media. 
 The author will have free access to the paper (after accepting the 
Terms & Conditions of use, they can view the article). 
 For non-open access articles, the corresponding author and co-
authors can nominate up to ten colleagues to receivea publication 
alert and free online access to the article. 
Promoting the Article 
To find out how to best promote an article, click here. 
Measuring the Impact of an Article 
Wiley also helps authors measure the impact of their research through 
specialist partnerships with Kudos and Altmetric. 
9. EDITORIAL OFFICE CONTACT DETAILS 
For help with submissions, please contact: Vicki Pang, Senior Editorial 
Assistant (papt@wiley.com) or phone +44 (0)1243 770 410. 
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Attachment, Information Processing, and Distress in Psychosis 
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REC Research Ethics Committee 
RFQ Reflective Functioning Questionnaire 
SAE Serious Adverse Event 
SAR Serious Adverse Reaction 
SIAS Social Interaction Anxiety Scale 
SOP Standard Operating Procedure 
INTRODUCTION 
The term 'psychosis' relates to a number of conditions which are 
characterized by alterations in a person's perceptions, thoughts, mood, and 
behaviour (NICE, 2004). During these alterations, positive and negative 
symptoms will occur in a combination unique to each individual (Kay, Opler, 
& Lindenmayer, 1988). Significant levels of stigma around psychosis 
continues to exist in society, with 87% of respondents to a recent report 
disclosing direct experience (Schizophrenia Commission, 2012). Research 
investigating the impact of these social experiences has indicated that 
stigmatizing social encounters may influence both the behaviour a person 
exhibits and the beliefs they hold (Mestdagh & Hansen, 2014). As such, it is 
necessary to give further consideration to the social and relational aspects of 
people's lives. 
When considering the social and relational aspects of people's lives it is 
possible to break these interactions down into two parts - the 'self' and the 
'other'. This is as an individual will be making attempts to interpret information 
so as to understand not only their own thoughts, feelings, and behaviours, 
but also of others within any given environment. Such attempts to interpret 
social information have led us to develop a number of strategies or 
processes. Although these processes allow people to make sense of how 
they think or feel about themselves and other people, they also allow for 
comparison. The comparative element of our cognitive processes provides 
an opportunity for people to understand themselves in relation to others. 
Effective processing of social information may be considered advantageous 
as accurate appraisals are suggested to serve a vital role in managing threat, 
specifically the potential threat of becoming socially rejected thus losing 
control over access to resources (Trower & Gilbert, 1989). Research has 
found that many people with psychosis associate their illness status with high 
levels of shame, blame, and fear of discrimination (Corrigan & Watson, 2002; 
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Brohan et al, 2010). As psychosis is a highly stigmatized diagnosis in society, 
it is important to investigate the ways in which information about themselves 
and other people is being processed. Greater clarity about the ways this 
information is being processed may advance our understanding of the impact 
it holds the potential to exert upon developmental pathways to distress. 
Psychosis and Psychological Distress 
People with psychosis commonly experience emotional disorders such as 
anxiety and depression, with the high prevalence of such comorbidities 
increasingly recognised within literature (Buckley, Miller, Lehrer, & Castle, 
2009). This study seeks to build upon the evidence base which has 
frequently taken generalised anxiety and depression as measures of distress. 
More recently, research has highlighted the role of shame in hampering 
emotional recovery from psychosis due to the strong association between 
shame and depression in this population (Keen et al., 2017). Research has 
also shown that the social anxiety experienced by a number of people with 
psychosis is associated with an internalisation of negative stereotypes 
(Pallanti et al., 2004). A more nuanced approach to emotional distress will be 
followed within this study, and include measures of shame and social anxiety 
alongside generalised anxiety and depression.  
Hartley, Barrowclough, and Haddock (2013) comment on the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) system, which is used by many 
in research within this area of interest. They (Hartley, Barrowclough, & 
Haddock, 2013) state that exclusion rules mean that emotional concerns are 
assimilated and the schizophrenia spectrum disorder takes primacy. Debate 
exists within the literature as to the extent of overlap between emotional 
disorder and symptomatology, with some suggesting for example that 
depression may be an intrinsic part of schizophrenia (Siris, 2004). There is 
therefore potential for a diagnosis of psychosis to overshadow an emotional 
disorder (Hartley, Barrowclough, & Haddock, 2013), and so the importance of 
exploring distress is highlighted.  
Distress and Cognitive Models in Psychosis  
Birchwood (2003) argues for the existence of three overlapping pathways to 
distress experienced as, for example, anxiety or depression in psychosis. 
The first pathway of emotional disorder and thus distress is described as 
intrinsic to psychosis. The second pathway reflects evidence that 
developmental trauma and social difficulties can act as risk factors for 
emotional disorder in psychosis (Bak et al., 2005). This is as cognitive 
schemas which blend experiences from the past and present influence 
information processing about the self and others (Beck, 1976). Therefore, a 
 
125 of 156 
 
 
schema may become active and either facilitate or disrupt adaptation to 
psychosis and its symptoms (Birchwood, 2003). For example, paranoid 
anxiety reinforced by a schema about the malevolent intent of others 
developed through experiences of childhood trauma may lead to greater 
levels of anxiety and avoidance coping.  
A third pathway considers the possibility of emotional disorder as a reaction 
to psychosis. This pathway is concerned with how individuals appraise the 
personal threat of their diagnosis of psychosis, by perceived shame due to 
stigma and changes in social rank (Birchwood, 2003). Birchwood et al. 
(2006) comment that receiving a diagnosis of psychosis may be experienced 
as a challenge, further than the challenge presented by symptoms, to an 
individual's identity due to issues of stigma and social desirability. This is 
consistent with the views of Morrison (2001) who emphasised that beliefs 
about cultural acceptability can shape the appraisals people make about their 
anomalous experiences. A diagnosis of psychosis may reinforce an 
individual's beliefs that their experiences are not culturally acceptable thus 
prompting reappraisal of social desirability. Distress experienced in the form 
of depression was noted by Iqbal, Birchwood, Chadwick and Trower (2000) 
in participants who held cognitive appraisals that their diagnosis of psychosis 
had enforced a lower social status. A psychological model of post psychotic 
depression suggests a cognitive process of regained insight might change 
illness appraisals and therefore the impact of diagnosis itself (Birchwood et al 
2005). However Gilbert (2000) argues that emotional expressions of distress 
such as shame, anxiety and depression might be conceptualised as 
submissive strategies when individuals find themselves in position of 
unwanted low status/social rank positions. This may mean that the emotional 
impact of diagnosis does not change with additional insight until the 
unwanted social ranking position is cognitively reappraised. 
The Impact of Attachment 
Attachment is described by Mikulincer, Shaver, and Pereg (2003) as one of 
the most important conceptual frameworks for understanding how an 
individual regulates their emotions when managing threat. As a result of 
interactions with caregivers during infancy and childhood, individuals develop 
mental representations of both the self in relation to others, and how others 
are expected to behave in social relationships (Bowlby, 1969). The 
attachment system functions to monitor and appraise potentially threatening 
events before activating mental representations of strategies to facilitate 
security with the aim of coping with any distress that arises from the threat 
(Mikulincer, Shaver, & Pereg, 2003). These mental representations are 
hypothesised to become working models which guide an individual's 
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attention, interpretations, and predictions about themselves and others within 
the social environment (Waters & Waters, 2006). 
It has been argued that there are clear overlaps between the constructs of 
self and other schemata in cognitive models of psychosis and Bowlby's 
working models, albeit with the caveat that working models are influenced to 
a greater extent by affective experiences (Berry, Barrowclough, & Wearden, 
2007). A relationship between internal working models and social rank may 
be noted through the internalisation of secure attachment where others are 
regarded safe/helpful/supportive, as this means safeness is activated 
socially. Conversely, those with insecure attachment may find social rank to 
be a source of threat, and due to their increased focus upon threat, an 
attentional bias towards issues of social rank may be observed (Laithwaite et 
al., 2009). If an individual perceives their diagnosis of psychosis as a threat, 
the attachment system will be activated and their individual working models 
might be expected to guide that person's attention, interpretations, and 
predictions about the themselves and others. Attachment theory might 
therefore be considered as a useful framework for understanding a person's 
adaptation to the experience of psychosis. 
Overall, a review of the literature has demonstrated that the processes 
underlying the development of distress as they relate to the adaptations 
people make to a diagnosis of psychosis and subsequent evaluations about 
their social environment remain unclear. If the distress a person with 
psychosis experiences as a result of stigma differs according to how they are 
processing information, this may have implications for the way services 
understand and treat such distress. The proposed study will further explore 
attachment, self and other processing, and distress in psychosis in the hope 
of further clarifying the relationship between each of these components. 
STUDY OBJECTIVES 
Primary Objective 
This study aims to explore the relationship between the patterns of how 
people relate to other people in order to have their needs met (attachment), 
the thoughts and feelings people use about themselves and others to make 
sense of social situations, and distress in people who experience psychosis. 
 
Secondary Objectives 
Does the way people who experience psychosis think about themselves and 
other people influence the relationship between attachment and distress? 
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Does the ability to think about and reflect upon their thoughts influence the 




Primary Outcome Measure 
The primary outcome is distress as measured by the Generalised Anxiety 
Disorder Scale, Social Interaction Anxiety Scale, and Calgary Depression 
Scale for Schizophrenia. 
Secondary Outcome Measures 
Secondary outcome measures for this study are putative mediators. They 
include the Personal Beliefs about Illness Questionnaire – Revised (PBIQ-R; 
Birchwood, Jackson, Brunet, Holden, & Barton, 2012) and the Reflective 
Functioning Questionnaire (RFQ; Fonagy et al., 2016). The extent to which 
these outcomes exerts influence over the relationship between attachment 
and distress will be tested. 
STUDY DESIGN 
This is a cross-sectional study that is expected to last for 1 year and 5 
months. A sample of 54 adults over the age of 16 with a diagnosis related to 
the symptoms of psychosis as determined by the treating clinician will be 
recruited to the study. This sample group will be drawn from the 3 NHS Forth 
Valley localities of Falkirk, Stirling, and Clackmannanshire. Individuals who 
meet the study inclusion criteria within those localities will be identified and 
offered the opportunity to participate by completing a pack of questionnaires 
and a semi-structured interview with the researcher. Information during 
interviews will be collected by means of standardised questionnaires 
regarding psychotic symptomatology, attachment, distress, cognitive 
appraisals, and reflective functioning. Those who can consent independently 
will be included in the sample. 
 
It is anticipated that participants will be in the study for a maximum of 1 
month. This accounts for the length of time it may take from participants 
giving verbal consent after being initially approached by their clinician to the 
scheduling of an appointment for completion of written consent and study 
measures. It also accounts for any time taken through the rescheduling of 
 
128 of 156 
 
 
meetings or the scheduling of a second meeting to complete study measures 
where appropriate, including at the request of participants. 
Three recruitment pathways will be used to identify potential participants from 
within secondary care services in NHS Forth Valley. The first recruitment 
pathway is via the Integrated Community Mental Health Services and will 
involve members of the multi-disciplinary team. The second recruitment 
pathway is via in-patient units and the Community Rehabilitation Team where 
members of the relevant multi-disciplinary team will be involved. In each 
recruitment pathway, clinicians will be contacted and provided with an 
information sheet about the study and asked to identify individuals on their 
current caseload who may meet inclusion criteria. Clinicians will then discuss 
the opportunity to participate in this research study with those individuals 
identified, and provide them with a participant information sheet. A self-
referral pathway will be available for individuals who attend clinics where 
posters advertising the study will be displayed on notice boards in NHS clinic 
waiting areas. The poster will provide a clear process for self-referral and ask 
those who are interested to contact their keyworker, who will know about the 
study and be able to provide additional information. Any keyworkers who 
receive a request from their client will discuss their wish to be included in the 
study will gather verbal consent from the client to follow this up with the 
registered clinician. The clinician will then be able to check the self-referred 
client meets inclusion criteria and provide a participant information sheet 
where appropriate. 
The clinician will then check back, at least 24 hours after potential 
participants have been provided with the participant information sheet, to ask 
whether the potential participant would like to participate in the study and 
give verbal consent for their contact details to be given to the researcher. 
Following this, potential participants will be contacted by the researcher to 
discuss what the study will involve and will be given at least 24 hours to 
consider whether they wish to participate. Participation will be voluntary, and 
all participants will continue their usual psychological, psychiatric and medical 
care during the study. Once a potential participant gives verbal consent to 
participate, the researcher will then liaise closely with the clinical team to 
discuss any relevant issues to their participation in the study. The participant 
will be invited to a one-off meeting that will be scheduled at a mutually 
agreed time/location such as in NHS locality clinic or home visit, with 
consideration of risk information, and adhere to local NHS lone-working 
policy. Participants will be informed during prior contact and information 
about the study that this meeting will last approximately 90 minutes but will 
include written consent, the questionnaire pack, and the semi-structured 
interview. Although this time is inclusive of breaks, participants may wish 
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instead to complete the questionnaire pack and semi-structured interview in 
two separate meetings of 40 minutes each; this will be facilitated by mutual 
agreement where appropriate. The clinician will be present during the 
completion of study measures and interviews will be audio-recorded for the 
purposes of ensuring coding accuracy. 
STUDY POPULATION 
NUMBER OF PARTICIPANTS 
A total of 54 adults with a diagnosis related to the symptoms of psychosis as 
determined by the treating clinician will be recruited to the study. The main 
recruitment window is over a period of 10 months from January to October 
2018. 
INCLUSION CRITERIA 
1) Individuals who are currently in contact with NHS mental health services 
2) Individuals who have a diagnosis related to the symptoms of psychosis as 
determined by the treating clinician 
3) Individuals aged 16+ who are willing to participate voluntarily and able to 
give written informed consent  
4) Individuals who have sufficient understanding of English to complete the 
measures. 
EXCLUSION CRITERIA 
1) Individuals not currently in contact with NHS mental health services  
2) Individuals with a history of organic factors implicated in the aetiology of 
psychotic symptoms e.g. brain injury 
3) Individuals who currently lack capacity to consent to research  
4) Individuals who have a level of understanding English which prevents 
completion of questionnaires 
PARTICIPANT SELECTION AND ENROLMENT 
IDENTIFYING PARTICIPANTS 
Clinicians will be contacted to discuss and identify individuals on their current 
caseload who may meet inclusion criteria. A self-referral pathway will be 
available for individuals who attend clinics where posters advertising the 
study will be displayed on notice boards in NHS clinic waiting areas. The 
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poster will provide a clear process for self-referral and ask those who are 
interested to contact their keyworker, who will know about the study and be 
able to provide additional information.  
CONSENTING PARTICIPANTS 
Potential participants will be provided with the Participant Information Sheet 
about the study, and will be given at least 24 hours to consider whether they 
wish to participate. Clinicians will not discuss personal or identifiable 
information with the researcher before potential participants have expressed 
an interest in taking part. 
Once a potential participant has given verbal consent to their clinician, the 
researcher will then discuss current presentation, issues pertaining to risk, 
potential for distress through engaging with this research, and capacity to 
consent with the clinician on an individual case-level basis. Those who agree 
to participate will meet with the researcher who will give potential participants 
the opportunity to ask any questions about the study and confirm inclusion 
criteria. A written consent form will then be completed by participants. 
 
Withdrawal of Study Participants 
Participants are free to withdraw from the study at any point or a participant 
can be withdrawn by the Investigator. If withdrawal occurs, the primary 
reason for withdrawal will be documented in the participant’s case report 
form, if possible. The participant will have the option of withdrawal from:  
(i) all aspects of the trial but continued use of data collected up to that point 
(ii) all aspects of the trial with removal of all previously collected data.   
 
All participants will be informed of their right to withdraw from the study at any 
stage they wish during the consent process. Should a participant become 
distressed during the completion of measures, they will be reminded of this 
right to withdraw. 
 
The researcher is a Trainee Clinical Psychologist and has observational 
experience of assessing capacity. If through discussions with the participant 
about the study prior to consent the researcher holds concerns about the 
participant's capacity to provide informed consent, the researcher will thank 
participants for their interest, advise that they do not meet inclusion criteria 
for the study, and contact details for the potential participant shall be 
destroyed.  
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If a participant who has given informed consent loses capacity to consent 
during the study, the participant and all identifiable data collected would be 
withdrawn from the study. Data which is not identifiable to the research team 
may be retained. 
STUDY ASSESSMENTS 
The questionnaire pack and semi-structured interview will be administered 
during a single meeting with the researcher unless a further appointment is 
requested by the participant and mutually agreed as appropriate. 
Demographic Data 
Relevant demographic data will be collected during the participant interview 
including; age, gender, relationship status, current medication, psychosis age 
of onset, and current psychiatric diagnosis/diagnoses.  
Psychosis Attachment Measure 
The Psychosis Attachment Measure (PAM; Berry, Wearden, Barrowclough, & 
Liversidge, 2006) is based on existing measures of attachment along the 
axes of anxiety and avoidance proposed by Bartholomew and Horowitz 
(1991) so as to reveal working models of the self and others. The PAM was 
adapted to reduce the strong emphasis on romantic relationships thus 
improving relevance to individuals with psychosis whose opportunities for 
such relationships may be significantly reduced. The self-report version of the 
PAM has 16 items, with participants asked to rate each item using a 4-point 
scale ranging from ‘not at all’ to ‘very much’. The PAM is suggested to have 
good psychometric properties with acceptable levels of internal consistency 
reported (Cronbach’s alpha for the dimensions of anxiety 0.82 and avoidance 
0.75) and concurrent validity in line with that demonstrated by other self-
report measures of attachment (Berry et al., 2006).  
 
The Personal Beliefs about Illness Questionnaire-Revised 
The Personal Beliefs about Illness Questionnaire – Revised (PBIQ-R; 
Birchwood, Jackson, Brunet, Holden, & Barton, 2012) is a 20-item self-report 
measure designed to reflect current constructs of social rank theory in 
relation to people experiencing psychosis. These five constructs are named 
as; shame, loss, entrapment, control over illness, and social 
marginalization/group fit. The scales do not reveal a total score, but instead 
are designed to be subjected to individual analysis whilst supporting the 
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undelying theoretical contruct. The PBIQ-R was found to be internally 
consistent (Cronbach alpha values for all five subscales between 0.7 and 
0.81) whilst being described as being reliable and satisfactory in both 
concurrent and discriminant validity (Birchwood et al., 2012).  
The Brief Core Schema Scales 
The Brief Core Schema Scale (BCSS; Fowler, et al., 2006) is a 24-item self-
report questionnaire that assesses beliefs about the self and others firstly by 
indicating yes/no before using a 4-point scale from ‘believe it slightly’ to 
‘believe it totally’ to indicate the strength of belief. Scores are obtained across 
four subscales; postive-self, positive-other, negative-self, negative-other. The 
BCSS was found to be internally consistent (Cronbach alpha values for all 
four subscales between 0.79 and 0.87), reliable, and satisfactory in validity 
during testing with a sample group of people with chronic psychosis (Fowler 
et al., 2006).  
The Reflective Functioning Questionnaire 
The Reflective Functoning Questionnaire (RFQ; Fonagy et al., 2016) is an 8-
item screening measure of reflective functioning. Each item of the measure 
provides a statement such as "I always know what I feel" to which 
participants are invited to respond using a 7-point scale from 'strongly 
disagreee' to 'strongly agree'. The RFQ is reported to hold satisfactory 
reliability and validity with across both clinical and non-clinical samples 
(Fonagy et al., 20016), however it is to be noted that this specific measure 
has not yet been used within psychosis research. 
The Generalized Anxiety Disorder 7-Item Scale  
The Generalized Anxiety Disorder Scale (GAD-7; Spitzer, Kroenke, Williams, 
& Lowe, 2006) is a 7-item self-report screening measure designed as a 
diagnostic and to assess symptom severity. Participants are invited to 
respond indicating how often they have been bothered by each of the seven 
itemised problems across four rating points from 'not at all' to 'nearly every 
day'. The GAD-7 is reported to posess excellent internal consistency 
Cronbach alpha = .92) alongside good reliability and validity  (Spitzer, 
Kroenke, Williams, & Lowe, 2006).  
The Social Interaction Anxiety Scale 
The Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998) is a self-
report questionnaire designed to assess generalised fears of social 
interaction. Participants are invited to “indicate the degree to which you feel 
the statement is characteristic or true about you” over a scale of 19 items 
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across five rating points from ‘not at all’ to ‘extremely’. High levels of reliability 
and validity were reported (Mattick & Clarke, 1998). The scale has been used 
frequently within research and notably by Gilbert (2000) who found social 
anxiety as measured by the SIAS to be strongly positively correlated with 
shame (0.58, p= <0.01) and depression (0.60, p= <0.01) within a clinical 
population.   
Approximate time to complete questionnaire pack: 40 minutes. 
Calgary Depression Scale for Schizophrenia 
The Calgary Depression Scale for Schizophrenia (CDSS; Addington, 
Addington, & Schissel, 1990) is a 9-item structured interview which is 
regularly used within research and has good psychometric properties 
including internal consistency (Cronbach alpha value of 0.75) and both 
convergent and discriminant validity. The CDSS has been described as 
useful for research with psychosis sample groups as it ensures separation 
from negative and extra pyramidal symptoms (Upthegrove et al., 2010).  
Positive and Negative Syndrome Scale 
The Positive and Negative Syndrome Scale (PANSS; Kay, Fiszbein, & Opfer, 
1987) is a 30-item interview-based instrument which is designed to provide a 
balanced representation of both positive and negative psychotic symptoms 
whilst gauging their relationship to each other. The interviewer rates each of 
the 30 items across a 7-point scale ranging from 'absent' to 'extreme'. The 
PANSS has been found to posess good psychometric properties, with 
support lent to the assertion that positive and negative scales are inversely 
intercorrelated once shared association with general psychopathology had 
been accounted for (Kay, Opler, & Lindenmayer, 1988).  
 
Approximate time to complete semi-structured interview: 40 minutes 
DATA COLLECTION 
Data will be collected during a one-off scheduled appointment with the 
researcher using the standardised measures noted above in Section 6, Study 
Assessments. The questionnaire pack and semi-structured interview will be 
administered by the researcher, Hannah Buckland, Trainee Clinical 
Psychologist. 
There is no requirement for the PANSS and CDSS to be audio-recorded 
during administration of the semi-structured interview. However in this study, 
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audio recording will take place to ensure accuracy of coding symptom 
responses. 
STATISTICS AND DATA ANALYSIS 
SAMPLE SIZE CALCULATION 
Sample size was calculated according to guidance within Fritz and 
MacKinnon's (2007) article on planning to test mediated effects. Mediation 
model pathways within this calculation were based upon the research 
question, 'Do cognitive appraisals about illness mediate the relationship 
between attachment and distress in people who experience psychosis?' with 
effect size estimates of 'a' and 'b' pathways drawn from previous research. 
 
 
To calculate the sample size required to achieve 0.8 power whilst detecting 
small, medium, and large effect sizes in the proposed study the 'a' pathway is 
the relationship between attachment and cognitive appraisal, and the 'b' 
pathway is the relationship between cognitive appraisal and distress. 
A number of studies have reported large effect sizes when exploring the 
relationship between attachment and cognitive appraisal (e.g. Rowe & 
Carnelley, 2003; Collins & Feeney, 2004; Sheinbaum et al., 2015). Whilst this 
has not been fully explored in a clinical population with a diagnosis of 
psychosis, Mikulincer and Florian (1995) found associations between 
attachment and the appraisals adults made of a real-life stressful situation. 
Their (Mikulincer & Florian, 1995) exploration into threat based cognitive 
appraisals of a stressful situation is relevant to the proposed study as the 
conceptualisation of diagnosis with psychosis as a stressful situation and 
potential source of threat for a person. As described previously in section 3.4 
it is the cognitive appraisal people make of their potentially threatening illness 
status that the PBIQ has been designed to measure. A large effect size was 
found by Michail and Birchwood (2013) when exploring the relationship 
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between the PBIQ and distress as operationalised by experiences of shame 
and anxiety in psychosis. 
As this initial mediation model is not wholly based upon previous studies with 
a psychosis population, a second mediation model was explored. In this 
model the 'a' pathway is the relationship between attachment and reflective 
functioning, and the 'b' pathway is the relationship between reflective 
functioning and distress.  
 
MacBeth et al. (2011) evaluated the relationship between attachment and 
reflective functioning in a first-episode psychosis sample group and reported 
large effects. Furthermore, Smith et al. (2006) reported moderate effect sizes 
when exploring the relationship between reflective functioning and distress as 
operationalised by experiences of depression and distress caused by 
auditory hallucinations in a sample group with a current diagnosis of non-
affective psychosis. 
Based upon these findings,  Fritz and MacKinnon (2007) suggest that a 
sample size of 34 participants should be used as a lower limit for 0.8 power. 
If recruitment proves successful and a sample size of 54 is reached then this 
will allow greater possibility of detecting for the potentially smaller effect sizes 
in a psychosis sample group as seen within the 'b' pathway of the second 
model with 0.8 power. 
 
These sample sizes are estimates when testing a simple mediation model 
using bias-corrected bootstrapping. Although bias-corrected bootstrapping 
can increase likelihood of Type I error,  Fritz and MacKinnon (2007) note this 
method to be acceptible, and found a sample size of between 50-100 to be 
present within almost a quarter of literature surveyed for mediation testing. 
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A scoping exercise has been completed within NHS Forth Valley secondary 
care services with the assistance of psychiatry, Community Psychiatric 
Nurses (CPNs), and psychology to estimate the available sample size.  
 
Clinical Psychologists working in each locality have stated their intention to 
support the recruitment of participants in that area. On discussing the 
proposed study within a Falkirk Community Mental Health Team (CMHT) 
multi-disciplinary meeting, the team and Consultant Psychiatrist felt that the 
lower limit of 34 participants could be found within that area alone. On 
meeting with CPNs from Clackmannanshire, it was estimated that each had a 
caseload of 8 people with psychosis, with between 3 and 5 of these people 
anticipated as likely to participate in the study. Similar figures from the Stirling 
area provide an estimated sample pool of 64 people and a likely yield of 24 
participants minimum.  
The opinion of clinical psychologists working within secondary care is that 
this population tend to be hard to access for research but that engagement, if 
measures can be completed in one sitting, is high. To maximise opportunities 
for access and thus engagement, a number of recruitment pathways have 
been outlined along with a marketing window. 
PROPOSED ANALYSES 
Data will be analysed using SPSS, with descriptive statistics explored 
through the calculation of mean (standard deviation) for continuous variables, 
and frequency percentages for categorical variables. All variables will be 
checked for normality using the Shapiro-Wilk test as despite possible 
concerns over its sensitivity in small sample sizes, it is widely regarded as 
the best test of normality and provides better power than the alternative 
Kolmogorov-Smirnov test (Ghasemi & Zahediasl, 2012). The outcome of this 
test for normality will inform the next steps of data analysis, as any 
assumptions about the distribution of data will need to be considered when 
selecting parametic or non-parametric tests.  
The relationships between key variables (symptoms, attachment, reflective 
functioning, cognitive appraisals, distress) will be explored. Both informant 
and self-rated attachment data will be explored for relationships with sub-
scale scores for the Personal Beliefs about Illness Questionnaire and Brief 
Core Schema Scale.  
It is hypothesised that self-other processing such as cognitive appraisals of 
social rank and reflective functioning may be the mechanism by which 
attachment exerts influence upon distress. To test this hypothesis single 
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mediation models will be independently employed. The first mediation model 
will use attachment as the predictor variable, cognitive appraisal (each of the 
5 PBIQ subscales in turn) as the mediator variable, and distress as the 
outcome variable. The second mediation model will use attachment as the 
predictor variable, reflective functioning as the mediator variable, and distress 
as the outcome variable. Data will be analysed using Hayes' (2013) 
PROCESS macro model 4 for SPSS which will allow for bias-corrected 
bootstrapping. Any post-hoc testing of mediators operating in parallel or 
serial, as may be the case with the two hypothesised mediators of cognitive 
appraisal and reflective function, will be exploratory with the intention of 





Consent related issues 
It is important that potential participants have an understanding of what the 
study is about and what will be required of them. Potential participants will be 
provided with verbal and written information in the form of a participant 
information sheet. Individuals approached to participate in the study will be 
informed that participation in the study will not affect their care and 
management. They will also be informed of their rights: declining participation 
in the study, withdrawing from the study at any stage and making a 
complaint. In each recruitment pathway, clinicians will be contacted to 
discuss and identify individuals on their current caseload who may meet 
inclusion criteria. Clinicians will confirm at this stage that the potential 
participant is able to give informed consent. The clinician will then provide all 
identified individuals with a study information sheet and offer the opportunity 
to participate in the study. The clinician/keyworker will then be asked to 
acquire consent from potential participants to be contacted by the researcher 
to discuss the study and arrange an appointment to meet. Following this, 
participants will be informed by the research assistant about the aims of the 
study and will be given at least 24 hours to consider whether they wish to 
participate. An opportunity to ask questions prior to consent will be given to 
all participants. Only individuals who provide written consent will be included 
in the study. Before they sign consent, all participants will be given an 
opportunity to ask any questions about the study and they will be informed 
about their rights. 
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In acknowledgement of the complexities which exist in managing risks 
related to capacity to consent, additional safeguards are proposed. Firstly, 
only those deemed holding the capacity to provide written informed consent 
will be invited to participate by the researcher. Secondly, written consent and 
completion of measures will take place within same appointment. 
Potential distress of participants 
During the administration of the psychological measures, participants with 
psychosis will be asked about their attachment, cognitions, and subsequent 
psychological distress. There is a possibility that a participant becomes 
distressed during the completion of measures. However, the selected 
questionnaires are widely used in research and clinical practice and evidence 
suggests that completion of these measures is unlikely to result in distress. 
Whilst the possibility of distress exists, it is of note that this may not be 
directly related to participating within the study. In consideration of both these 
eventualities, the researcher will be present whilst participants complete the 
measures to monitor levels of distress, thus assisting with the management 
of clinical risk. The researcher will take care to discuss any concerns of risk 
to participants and early warning signs for distress. Participants will also be 
encouraged to discuss any upsetting issues with clinical staff who are 
involved in their routine care. Despite these researcher-led strategies to 
manage the risk of participant distress, it is important to consider the 
participant themselves as a partner in managing this risk. All participants will 
have capacity to provide informed consent and as such are autonomous 
individuals with the ability to make their own choices in the participation of 
this study. Participants will be made aware of the content of each 
questionnaire, and their right to withdraw from the study including during 
completing measures. They will therefore be considered able to decide 
whether to continue participating throughout their appointment when 
completing the questionnaire pack. 
Risk management and confidentiality 
The participant's right to confidentiality will be stated within the process of 
gathering informed consent. Time will be taken to discuss the boundaries of 
this and the occasions when the researcher would disclose information to the 
participant's care team. This explanation of confidentiality will be drawn from 
standard procedure and highlight the researcher's responsibility to share 
information if she becomes concerned that there is a risk of harm to either 
the participant themselves or to others. If the researcher becomes aware of a 
risk of harm to either the participant or others then this will be managed 
according to local NHS risk management policy and procedures whilst 
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liaising closely with the clinical team. Appointments will be made in 
adherence with NHS lone-working and health and safety policies so as to 
facilitate access to the clinical team. 
Data protection 
Hard copies of questionnaires will be stored in a locked cabinet within the 
psychology department and any transportation of completed participant 
questionnaires between NHS sites will take place using a locked briefcase as 
per NHS Forth Valley protocols. Anonymised data will be entered into an 
electronic database and stored in accordance with the NHS Forth Valley 
Information Management Policy. This is to ensure that access is limited only 
to those who need to access the information, whether this is paper or 
electronic data records. Non-identifiable data will be made available to the 
academic supervisor where necessary following guidance within the NHS 
Information Sharing Policy and adhering to Caldicott Principles. Following 
completion of the research, both paper copies and electronic data will be 
retained and subsequently disposed of according to University of Edinburgh 
and NHS Forth Valley Records Management Code of Practice. This is to 
ensure data is stored securely and destroyed appropriately. 
OVERSIGHT ARRANGEMENTS 
INSPECTION OF RECORDS 
Investigators and institutions involved in the study will permit trial related 
monitoring and audits on behalf of the sponsor, REC review, and regulatory 
inspection(s).  In the event of audit or monitoring, the Investigator agrees to 
allow the representatives of the sponsor direct access to all study records 
and source documentation. In the event of regulatory inspection, the 
Investigator agrees to allow inspectors direct access to all study records and 
source documentation. 
RISK ASSESSMENT 
1) Failure to receive ethical approval 
It is anticipated that the NHS Research Ethics Committee may raise 
concerns around possible adverse outcomes to participants from the 
completion of questionnaires. All measures within the study have been 
chosen due to their routine use within research or clinical practice with 
individuals who experience psychosis. As participants are already receiving 
input from NHS health care services, it is likely that they will have prior 
experience of either these specific questionnaires or ones with a similar 
focus.  
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Informed consent will be sought before individuals participate in the study. 
The process of gaining informed consent will include detailing the types of 
questions participants will be asked whilst ensuring individuals are aware of 
their right to withdraw from participating at any time, including during the 
completion of study questionnaires. The researcher will be present at all 
times whilst participants complete the questionnaires and will therefore be 
available to support participants or address distress should any arise.  
2) Failure to recruit sufficient sample size 
There is a risk that sufficient participant numbers will not be recruited to the 
study.  
A marketing window of 2 months is proposed as this allows for attendance at 
each of the team meetings to raise awareness about the study. The trainee 
and researcher has been visiting psychiatry and CMHT departments within 
each locality in NHS Forth Valley since the beginning of first year. It is hoped 
that this will enable positive relationships with staff and clinical teams to be 
developed before initiation of study marketing and data collection.  
A recruitment window of 12 months, inclusive of the 2 month marketing 
window, has been identified which allows time for a recruitment rate of 
approximately 4 participants per month assuming a sample size of 54. 
Should recruitment not progress as hoped, a lower limit sample of 34 may be 
acceptable (please see section 4.1 for further details of lower limits as related 
to individual mediation models), thus leading to a recruitment rate of 
approximately 3 participants per month over 12 months.   
 
A number of recruitment pathways are proposed so as to encourage 
engagement from individuals with psychosis who access services in a variety 
of ways. Few recent research projects have recruited people with psychosis 
in NHS Forth Valley and so there is a reduced risk of competition from other 
projects and increased opportunity for accessing participants whose views 
have not already been sought. It is hoped that sufficient numbers will be 
recruited from within NHS Forth Valley, however through early discussion it is 
notable that a multi-site ethics application is supported should this risk need 
further mitigation. 
3) Reliance on others to access potential participants 
The study involves some reliance on clinicians to identify potential 
participants on their current caseload and feed this information back to the 
researcher. To reduce the risk of communication breaking down leading to an 
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insufficient sample size being recruited, time has been spent (see above) to 
ensure the researcher is known to clinicians  so that positive working 
relationships can be developed and maintained. 
Furthermore, a self-referral recruitment pathway is proposed to reduce the 
researcher's reliance on others to achieve the full sample size. 
STUDY MONITORING AND AUDIT 
The Research Governance and QA office (University of Edinburgh) will 
review the study and determine if an independent risk assessment will be 
performed by an ACCORD Clinical Trials Monitor to decide (a) if monitoring 
is required and (b) if so, at what level. An independent risk assessment may 
also be carried out by the ACCORD Quality Assurance Group to determine if 
an audit should be performed before, during and/or after the study and if so, 
at what locations and at what frequency. 
The researcher will meet with the academic supervisor once a month for the 
duration of the project to monitor recruitment in relation to targets; deal with 
any adverse events; and coordinate the different stages of the project from 
recruitment to analysis and dissemination of results. The researcher will 
update the clinical supervisor about progress on a monthly basis following 
academic supervision meetings, and meet to discuss clinical issues relating 
to the project when appropriate. Collaborative discussion between the 
supervisory team and the researcher will take place by telephone 
conferencing and email contact. Day-to-day project management including 
administrative issues, troubleshooting and recruitment flow will be the 
responsibility of Hannah Buckland (researcher and trainee clinical 
psychologist). 
GOOD CLINICAL PRACTICE 
ETHICAL CONDUCT 
The study will be conducted in accordance with the principles of the 
International Conference on Harmonisation Tripartite Guideline for Good 
Clinical Practice (ICH GCP). 
Before the study can commence, all required approvals will be obtained and 
any conditions of approvals will be met. 
 
 




The Investigator is responsible for the overall conduct of the study at the site 
and compliance with the protocol and any protocol amendments.  In 
accordance with the principles of ICH GCP, the following areas listed in this 
section are also the responsibility of the Investigator.  Responsibilities may 
be delegated to an appropriate member of study site staff.   
Informed Consent 
In recognition of differences in the capacity people with psychosis have to 
provide fully informed consent, the registered clinician will consider their 
caseload and approach potential participants according to their clinical 
assessment of capacity. Clinicians will confirm that potential participants 
meet study inclusion criteria and have the capacity to provide informed 
consent. When initially approached by a clinician from their direct care team 
about their interest in the study, potential participants will be provided with 
the Participant Information Sheet for the study. This will detail what is 
involved in participating in the study. Individuals approached to participate in 
the study will be informed that participation in the study will not affect their 
care and management. They will also be informed of their rights: declining 
participation in the study, withdrawing from the study at any stage and 
making a complaint.  
The clinician/keyworker will then be asked to acquire verbal consent from 
potential participants to be contacted by the researcher to discuss the study 
and arrange an appointment to meet. There will be a minimum of 24 hours 
between potential participants providing consent for clinicians to share their 
contact details and meeting the researcher to gather written consent. 
Following this, participants will be informed by the researcher about the aims 
of the study and will be given at least 24 hours to consider whether they wish 
to participate.  
 
At this meeting, potential participants will have details of the study fully 
clarified and will have the opportunity to ask any questions. The researcher is 
a Trainee Clinical Psychologist and has observational experience of 
assessing capacity. If through discussions with the participant the researcher 
holds concerns about the participant's capacity to provide informed consent, 
the researcher will thank participants for their interest, advise that they do not 
meet  inclusion criteria for the study, and contact details for the potential 
participant shall be destroyed. 
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After having the opportunity to ask any questions, potential participants will 
be asked to indicate whether or not they wish to participate in the study. If 
they wish to participate in the study, they will be asked to sign a consent 
form. It will again be made clear by the researcher that the potential 
participant can take more time to consider whether they wish to participate. It 
will also be made clear that participation is voluntary and neither their 
participation or non participation will affect their treatment as usual (whatever 
they receive as part of normal routine care). Only individuals who provide 
written consent will be included in the study. 
Participants will receive both oral and written information when discussing 
their potential participation in the study. Appropriate Participant Information 
and Informed Consent Forms will be provided to support this discussion with 
the researcher. The researcher and the participant will sign and date the 
Informed Consent Form to confirm that consent has been obtained. The 
original copy will be retained in the site file, one copy is to be retained in 
patient notes, and one copy is to be retained by the participant. 
 
In acknowledgement of the complexities which exist in managing risks 
related to capacity to consent, additional safeguards are proposed. Firstly, 
only those deemed holding the capacity to provide written informed consent 
will be invited to participate by the researcher. Secondly, written consent and 
completion of measures will take place within the same appointment. 
Study Site Staff 
The Investigator must be familiar with the protocol and the study 
requirements. It is the Investigator’s responsibility to ensure that all staff 
assisting with the study are adequately informed about the protocol and their 
study related duties. 
Data Recording 
The Principal Investigator is responsible for the quality of the data recorded.  
Confidentiality 
The participant's right to confidentiality will be stated within the process of 
gathering informed consent. Time will be taken to discuss the boundaries of 
this and the occasions when the researcher would disclose information to the 
participant's care team. This explanation of confidentiality will be drawn from 
standard procedure and highlight the researcher's responsibility to share 
information if she becomes concerned that there is a risk of harm to either 
the participant themselves or to others. If the researcher becomes aware of a 
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risk of harm to either the participant or others then this will be managed 
according to local NHS risk management policy and procedures whilst 
liaising closely with the clinical team. Appointments will be made in 
adherence with NHS lone-working and health and safety policies so as to 
facilitate access to the clinical team. 
Data Protection 
The transfer of personal data such as address, postcode, or telephone 
number may take place between clinicians and the researcher via email 
following the identification of potential participants who have verbally 
consented to contact from the researcher. Personal data will only be provided 
to the researcher by clinicians following discussion with the potential 
participant and their verbal consent to receiving contact from the researcher 
by whichever method as appropriate. Personal data will then be stored on an 
electronic database in accordance with NHS Forth Valley Information 
Management policy and any email records deleted. 
Personal data collected through the consent process will be stored 
separately in hard-copy form. Paper files will be kept in a locked cabinet in 
the Department of Clinical Psychology, Mayfield Building, Falkirk Community 
Hospital. Anonymised data will be entered into an electronic database and 
stored in accordance with the NHS Forth Valley Information Management 
Policy. This is to ensure that access is limited only to those who need to 
access the information, whether this is paper or electronic data records. Non-
identifiable data will be made available to the academic supervisor where 
necessary following guidance within the NHS Information Sharing Policy and 
adhering to Caldicott Principles. 
The use of an audio recording device will be used during semi-structured 
interviews and may thus record personal data during the study. For the 
purposes of this study, an NHS encrypted audio recording device will be 
used and the NHS Forth Valley policy on use of such devices will be 
followed. The use of an audio recording device is not mandatory for the 
administration of the semi-structured interview, however data recorded will be 
used to check for accuracy of symptom recording and destroyed after coding 
of responses is recorded.  
The study will adhere to the principles of Good Clinical Practice thus ensuring 
the confidentiality of personal data. Access to participant's personal data 
outwith the direct care team will be in accordance with NHS Information 
Sharing Policy. As such, the researcher will receive only the participant's 
name, contact telephone number and/or address, after participants have 
given permission for this to be provided. Storage of a password protected list 
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will follow NHS Information Management Policy and will be held separately 
on a restricted access area of NHS Forth Valley's server. Consent forms will 
comprise the link between a participant's name and their study ID number. As 
such, consent forms will be stored separately from all other data collected. 
Data collected through questionnaire and semi-structured interview will be 
labelled with the participant's ID code number. The electronic dataset will 
only hold anonymised data. The audio recording device will be NHS 
encrypted and interviews will be deleted after coding of responses is 
recorded. Any transportation of completed participant questionnaires and the 
audio recording device between NHS sites will take place using a locked 
briefcase as per NHS Forth Valley protocols. 
STUDY CONDUCT RESPONSIBILITIES 
PROTOCOL AMENDMENTS 
Any changes in research activity, except those necessary to remove an 
apparent, immediate hazard to the participant in the case of an urgent safety 
measure, must be reviewed and approved by the Chief Investigator in 
collaboration with the supervisory team.   
Amendments will be submitted to a sponsor representative for review and 
authorisation before being submitted in writing to the appropriate REC, and 
local R&D for approval prior to participants being enrolled into an amended 
protocol. 
MANAGEMENT OF PROTOCOL NON COMPLIANCE 
Protocol deviations will be recorded in a protocol deviation log and will be 
reported to the sponsor within 3 days of becoming aware of the violation.   
SERIOUS BREACH REQUIREMENTS 
A serious breach is a breach which is likely to effect to a significant degree: 
(a) the safety or physical or mental integrity of the participants of the trial; or 
(b) the scientific value of the trial. 
If a potential serious breach is identified by the Chief investigator or 
supervisory team, the co-sponsors (seriousbreach@accord.scot) will be 
notified within 24 hours. It will then be determined whether the incident 
constitutes a serious breach and report to research ethics committees as 
necessary.  
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STUDY RECORD RETENTION 
All study documentation will be kept for a minimum of 3 years from the 
protocol defined end of study point. When the minimum retention period has 
elapsed, study documentation will not be destroyed without permission from 
the sponsor. 
Following completion of the research, both paper copies and electronic data 
will be retained and subsequently disposed of according to University of 
Edinburgh and NHS Forth Valley Records Management Code of Practice. 
This is to ensure data is stored securely and destroyed appropriately. 
All paper copies of participant data will be stored in a locked cupboard within 
the Clinical Psychology Department at NHS Forth Valley. The box containing 
paper data will be clearly labelled as containing confidential data and a 10 
year destroy date as per standard departmental practice to ensure data is 
stored securely and destroyed appropriately. The anonymised electronic 
dataset will be retained and held within the University of Edinburgh repository 
so as to adhere to the Scottish Executive Research Governance Framework 
(2006) and enable suitable archiving of data which may be later requested for 
checks. The Chief Investigator (Hannah Buckland) and Academic Supervisor 
(Dr Helen Griffiths) will be named as custodians for this archived data, as per 
the proposals agreed by the Joint Training Committee. 
END OF STUDY 
The end of study is defined as the last participant’s last visit.   
The Investigators or the co-sponsor(s) have the right at any time to terminate 
the study for clinical or administrative reasons.  
The end of the study will be reported to the REC, and R+D Office(s) and co-
sponsors within 90 days, or 15 days if the study is terminated prematurely. 
The Investigators will inform participants of the premature study closure and 
ensure that the appropriate follow up is arranged for all participants involved. 
End of study notification will be reported to the co-sponsors via email to 
resgov@accord.scot.  
A summary report of the study will be provided to the REC within 1 year of 
the end of the study. 
INSURANCE AND INDEMNITY 
The co-sponsors are responsible for ensuring proper provision has been 
made for insurance or indemnity to cover their liability and the liability of the 
Chief Investigator and staff. 
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The following arrangements are in place to fulfil the co-sponsors' 
responsibilities: 
 The Protocol has been designed by the Chief Investigator and 
researchers employed by the University and collaborators.  The 
University has insurance in place (which includes no-fault 
compensation) for negligent harm caused by poor protocol design by 
the Chief Investigator and researchers employed by the University. 
 Sites participating in the study will be liable for clinical negligence 
and other negligent harm to individuals taking part in the study and 
covered by the duty of care owed to them by the sites concerned.  
The co-sponsors require individual sites participating in the study to 
arrange for their own insurance or indemnity in respect of these 
liabilities. 
 Sites which are part of the United Kingdom's National Health Service 
will have the benefit of NHS Indemnity. 
REPORTING, PUBLICATIONS AND NOTIFICATION OF RESULTS 
The study results will be reported and disseminated primarily through a 
portfolio thesis which will be submitted to fulfil the requirements of a 
Doctorate in Clinical Psychology at the University of Edinburgh. This 
document, once finalised, will be available through the Department of Clinical 
Psychology's Thesis Database to ensure open access for interested parties. 
 
The overall results of this study (but not individual scores) will be presented 
to each of the clinical teams involved within the research. These findings will 
be disseminated back to NHS staff who were involved in the study through 
team meetings and an end-of-study newsletter. Participants will also be given 
the opportunity to request an overview of findings following study completion. 
 
The systematic review and empirical study will be prepared for submission to 
peer-reviewed scientific journals such as Schizophrenia Research. The 
researcher will also identify and apply to present at relevant conferences 
following completion of the project. 
AUTHORSHIP POLICY 
Ownership of the data arising from this study resides with the study team.   
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